Watch · 66/100 · medium confidence

Accenture plc (ACN) — Council Assessment

🟡 WATCH · Score 66/100 · medium confidence

Elite-quality, net-cash cash machine trading at ~10x earnings after a 50% crash — a compelling value setup that hinges entirely on whether AI structurally hollows out its FTE consulting model.

As of 2026-06-27. 18 lenses weighed in, 0 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

Accenture (ACN) — Investment Briefing

Management Commentary (Earnings Call)

Headline Results (Q3 FY2026, ended May 31)

Revenue: $18.7B (+3% LCY, +6% USD); tracking to midpoint of guided range
EPS: $3.80 (+9% YoY)
Operating margin: 17% (+20 bps YoY)
Free cash flow: $3.6B; returned $2.2B to shareholders (buybacks + dividends)
New bookings: $19.3B (2% decline USD / -3% LCY, book-to-bill 1.0)

Headwinds Called Out

Middle East conflict impact: ~$100M revenue drag (all consulting), split between direct ME impact and indirect global effects (products, discretionary spend). Management expects this to persist into Q4.
Managed services slippage: Couple of large deals pushed to FY27 for company-specific reasons; no material Q4 recovery expected.
Federal business headwind: ~1.5% drag in Americas; expected to return to growth in Q4.

FY2026 Guidance (updated)

Full-year revenue: 3–4% LCY growth (1% federal drag; 4–5% ex-federal)
Adjusted operating margin: 15.8% (+20 bps vs. FY25)
Adjusted EPS: $13.78–$13.90 (7–8% growth)
Free cash flow: $10.8–$11.5B
Shareholder returns: ≥$9.5B (dividends + buybacks)
"More of the range is in play" due to macro uncertainty; management flagged consulting in Q4 will remain under pressure from ME indirect effects, automotive sector challenges, longer decision cycles in EMEA.

Capital Deployment

Now deploying ~$9B in acquisitions this year (vs. $5B guided): majority in three OT cybersecurity platforms announced today (Dragos, RunZero, NetRise).
Inorganic contribution forecast: ~1.5% in FY26; entry into FY27 at slightly under 2%.
Additional M&A (Alpha Health, Whaler) in digital health and creative agencies.

Strategic Positioning

AI as tailwind: 100 new clients initiated advanced AI projects this quarter (still early innings). Large enterprise AI transformations scaling from pilots to production; examples cited: British Telecom, Stellantis, Vodafone, Delantis. Moving clients from "using AI" to "running on AI."
104 clients with $100M+ quarterly bookings YTD (9-month basis), up 13% YoY—seen as key indicator of deal depth and reinvention program scale.
Mid-market expansion: Launching "Accenture Edge" next week targeting $300M–$3B revenue companies (~$240B TAM, high single-digit growth). Embedded Accenture expertise in repeatable, faster-deploy solutions; leverages Avanade (Microsoft JV) for cloud/AI/security.
Non-FTE commercial models: Acquisitions in cybersecurity software (Dragos ARR $208M, growing 48%), Alpha Health, Whaler shift portfolio away from pure FTE consulting. OT security TAM tripled.
Ecosystem deepening: Bookings from top 10 AI/data partners (OpenAI, NVIDIA, Databricks, Mistral, Anthropic, Palantier, Snowflake, etc.) tracking to >2x FY25 levels.

Tone & Candor

Management was candid about near-term headwinds (Middle East, managed services timing, macro uncertainty), explicitly saying "more of the range is in play."
Strong emphasis on long-term AI tailwind and TAM expansion to offset near-term discretionary budget pressure on large enterprise consulting.
Heavy investment narrative: 124K promotions (30% increase YoY), 900+ to managing director level; significant reinvestment in people and technology despite margin expansion.

Notable Q&A Exchanges

Consulting revenue–bookings disconnect (Jason Kupferberg, Wells Fargo): Middle East consulting work down $100M; consulting expected to remain in low single digits for FY26. However, management noted consulting within managed services deals is growing (clients embedding AI expertise into ops programs).
M&A risk & OT security thesis (Genevieve Morgan): Management framed OT security as critical AI enabler ("you can't have AI without critical infrastructure security"). Acquisition integration risk downplayed; positioned as platform consolidation (Dragos + RunZero + NetRise) bringing fragmented solutions under one contract.
Margin protection if range skews low: Angie Park emphasized margin/EPS targets being hit for the year; implied flexibility in cost/SG&A should revenue soften, though no explicit guardrails given.

Recent Developments

OT Cybersecurity Acquisitions (announced Q3 call, Jun 18): Accenture acquiring majority stakes in Dragos (platform), RunZero (vulnerability assessment), and NetRise (device security). Combined ARR ~$208M, growing 48%. Closes expected FY26; ~$9B M&A deployment this year.
Accenture Edge Launch (next week post-call): New business unit targeting mid-market ($300M–$3B revenue firms), embedded with Accenture enterprise expertise, repeatable solutions, integrated with Avanade.
Promotions & Headcount: 124K promotions this FY (30% increase YoY); 798K+ total headcount.
Dividend Increase: Quarterly dividend raised 10% to $1.63/share; $1B paid in Q3, $8.2B YTD returned to shareholders.
Federal Business: Continuing to drag (~1.5% impact), but expected to lap headwinds in Q4.

Bull Narrative

Who: Retail bulls, some consensus analysts (TIKR.com, Dividendology) citing valuation.

Arguments:

Valuation reset: Stock down ~50% YTD; now trading at ~10x PE (equity research notes), ~65% below historical multiples. Trading below historical free cash flow growth implied by valuation.
AI TAM expansion: Mid-market opportunity ($240B) is untapped. OT security platform tripled addressable market in that vertical (growing double digit). Dragos ARR $208M at 48% growth suggests high-margin, recurring revenue mix shift.
Durable client relationships: 195 of top 200 clients >10 years; 104 $100M+ bookings YTD (+13% YoY). Large program wins (BT, Stellantis, Vodafone) show clients moving beyond pilots to production AI programs.
Margin expansion discipline: Operating margin +20 bps YoY despite heavy reinvestment; adjusted margin guidance 15.8% (20 bps expansion). Strong FCF conversion (1.30x net income ratio).
Capital returns: Aggressive buyback, 10% dividend raise; management returning $9.5B+ despite elevated M&A spend.
Platform shift upside: Non-FTE acquisitions (Dragos, Alpha Health) position for higher-margin, stickier revenue; cited as key lever for next phase of growth.

Bear Narrative

Who: Retail skeptics (X/Twitter, options traders), some sell-side consensus (Truist cut PT post-earnings).

Arguments:

Demand destruction from macro uncertainty & AI competition: Stock crash reflects deep anxiety about Accenture's consulting moat. Management's own language—"more of the range is in play," $100M Middle East headwind, managed services deals slipping—signals confidence is fraying.
Discretionary services at risk: Large enterprise consulting is discretionary; clients cutting spend amid macro uncertainty and building in-house AI capabilities. The low single-digit consulting growth guidance for FY26 is weak for a $200B+ TAM leader.
AI margin compression risk: AI agents and LLMs may structurally damage enterprise software subscription and consulting economics (per @AXLFI_HQ thread). Clients may not need as many FTEs or managed services if AI automation accelerates.
Execution risk on non-FTE shift: Management betting on software/platform acquisitions (Dragos, Alpha Health) to offset consulting slowdown, but these are still small relative to $60B+ services base. Integration risk; high valuations in cybersecurity sector historically compressed post-close.
Fed drag, geopolitical noise ongoing: Federal business headwind structural; Middle East tensions unresolved. Management signaling these are "in the range" but no clear path to resolution.
Valuation "death trap": One retail trader noted "dead money" risk—stock grinds sideways for years, or compresses further if growth disappoints. 10x PE is "cheap" only if earnings don't fall materially.
Analyst downgrades: Truist cut price target post-earnings; options market pricing significant vol, suggesting uncertain outlook.

Retail Sentiment

Tone: Mixed, leaning bearish to cautious.

Bullish voices (minority):

Value investors citing 65% discount to historical multiples, strong dividend (5%+ yield), core long-term holdings despite volatility.
"Show me" attitude: believers want earnings to stabilize before re-rating; some accumulating on weakness.

Bearish voices (dominant):

"Dead money" / structural impairment thesis gaining traction. Stock crashed 50% YTD; retail conviction weak.
AI disruption narrative: belief that AI agents hollow out consulting margin and headcount demand.
Culture/morale concerns: one contributor noted MDs quiet on LinkedIn, "real culture of fear" post-earnings, linking to DEI/layoff environment (anecdotal).
Shorts emphasizing guidance language as warning; "needs big staff to die" to prove concept, will be shorted.

Overall conviction: Low. Retail mostly watching, not accumulating; sentiment cautious and fragile. Options market showing unusual put/call activity (per Barchart), suggesting hedging demand.

Caveats

Thin data on Middle East impact trajectory: Management admits last few weeks saw spike; no forward model provided. Could be transient or structural; unclear.
Managed services deal timing opaque: "Company-specific reasons" for FY27 pushout; actual magnitude and recoverability unknown.
Accenture Edge unproven: Launches "next week" but no early traction metrics, go-to-market detail, or unit economics disclosed. Framed as TAM expansion, but execution risk is real.
OT security platform integration hype: Management downplayed stitching risk (Dragos + RunZero + NetRise); no detail on post-close revenue synergy, churn, or customer receptivity.
Guidance range widening is red flag: "More of the range is in play" + discretionary budget pressure + federal headwind + Middle East uncertainty = low visibility. Bottom-end ($13.78 EPS) implies earnings risk.
M&A capital deployment ($9B) may not yield returns immediately: Accenture has executed well on acquisitions historically, but $208M Dragos ARR at 48% growth is small relative to overall base; time-to-scale unclear.
Analyst coverage fragmented: Most sell-side on sidelines post-crash; retail sentiment anecdotal, not systematically tracked.
No earnings call transcript for recent sessions post-June 18: Unable to assess follow-up questions or latest analyst concerns in real time.

Summary for Investment Council

Key Facts:

Q3 delivered mid-range results (3% LCY growth, 9% EPS growth), but management signaled macro headwinds (Middle East, managed services timing, federal drag) will persist into Q4.
Announced $9B M&A (OT cybersecurity focus) and new mid-market business (Accenture Edge) to expand TAM and shift to higher-margin, non-FTE models.
Stock down ~50% YTD; trading at 10x PE (valuation reset) but on uncertain earnings trajectory.

Bull Case: Valuation deep; AI TAM expansion real; client relationships durable; margin discipline intact; capital returns aggressive. Mid-market & cybersecurity platforms are genuine growth vectors if execution succe

Bull case

Multiple lenses (Buffett 76, Greenblatt 78, Munger 78, Damodaran referee 82, Mauboussin 74, Marks 74) converge on a genuinely high-quality franchise mispriced by fear. ROIC of 26% vs ~10% WACC is a durable ~1,600bps spread; asset-light ($600M capex on $70B revenue); FCF of $10.9B exceeds net income (1.4x conversion, forensically clean); net cash of $9.6B and no debt. At 7.3x P/FCF and 10.3x P/E, the market implies persistent ~-10% FCF decline — pricing in near-total consulting displacement. Even the conservative EPV (~$139) and bear DCF ($215) sit at or above the $129 price. 195 of top 200 clients retained 10+ years evidence a real switching-cost moat, and management is returning $9.5B+ to holders with buybacks highly accretive at these levels.

Bear case

The AI/Disruption referee (48) frames the core tension: Accenture sells human expertise packaged as billable hours — precisely what LLMs automate — and the 50% decline looks like the market pricing structural, not cyclical, impairment (the classic Christensen 'cheap on strong current cash flows' trap). Druckenmiller (28) and Schloss (22) reject it outright: tape in free-fall, second derivative negative (bookings -2-3% LCY, consulting guided to low-single-digits, managed services slipping to FY27, guidance range widened), and no hard asset floor (net current assets only ~$13/share). The $9B M&A acceleration (vs $5B guided) into OT cybersecurity draws serial-acquirer / diworsification flags from Fisher, Smith, Lynch and the forensic short-seller, while the Dragos-scale non-FTE pivot ($208M ARR) is de minimis vs a $70B base. Hyperscaler encirclement (Microsoft/Copilot, its own JV partner) is a direct competitive threat. The DCF's 70.6% terminal-value dependence and a possibly one-off FY25 FCF jump (26% YoY) weaken the margin-of-safety math.

Dissent — where the council disagrees

The council is sharply split, not merely cautious. Druckenmiller (AVOID 28) and Schloss (AVOID 22) dissent hardest — Druckenmiller because forward earnings direction is deteriorating with no catalyst (a 'backward-looking cheap trap'), Schloss because there's no tangible-asset floor. Crucially, the AI/Disruption referee (WATCH 48) — the most topic-relevant lens — believes the market may be correctly pricing forward demand destruction the value lenses are misreading as opportunity. This directly contradicts the value/quality bulls (Buffett, Munger, Greenblatt, Damodaran, Marks), whose entire thesis rests on the earnings base being durable. That single unresolved question — is FY25 earnings a peak or a trough? — is the whole decision, and even sympathetic quality investors (Akre 62, Terry Smith 62, Fisher 52, Klarman 52) land on WATCH precisely because the moat's most important leg (reinvestment runway / FTE demand) cannot yet be verified.

Key risks

AI/LLM agents structurally compress FTE consulting demand and margins — a regime-independent impairment, not a cyclical dip
$9B M&A acceleration (vs $5B guided) into OT cybersecurity risks capital misallocation, goodwill build, and diworsification
Hyperscaler encirclement: Microsoft/AWS/Google bundling consulting-adjacent AI automation, with Microsoft being both JV partner and competitor
Guidance range widening ('more of the range is in play'), softening bookings (book-to-bill 1.0), and managed services slippage signal low forward visibility
DCF intrinsic value is 70.6% terminal value; FY25 FCF jumped 26% YoY, raising a normalization question that could overstate the base

Catalysts

Consulting revenue reaccelerating above low-single-digits, confirming demand is cyclical not structural
Non-FTE / platform revenue mix (OT security ARR toward $1B+, Accenture Edge traction) reaching material scale by FY27-28
Continued aggressive buybacks at ~7x FCF shrinking share count and supporting per-share value
Resolution/reversal of federal drag and Middle East headwind in FY27
Evidence that AI transformation work expands (not contracts) integration demand, re-rating the multiple toward historical 20x+

DCF valuation (finance-expert model)

two-stage DCF, Gordon terminal value, CAPM-weighted WACC.

Intrinsic value: $261.37/share vs price $128.98 → +103% (bear $215.24 · base $261.37 · bull $323.97).

Step	Value
Base free cash flow	$10.9B
FCF growth (yrs 1-5)	4.2% (revenue CAGR)
WACC (β 1.166)	10.1%
Terminal growth	2.5%
PV of explicit FCF	$46.2B
PV of terminal (residual) value	$110.7B (71% of EV)
Enterprise value	$156.8B
less Net debt	$-9.6B
= Equity value	$166.5B
/ Shares (637M) = intrinsic/share	$261.37

⚠️ intrinsic value diverges >100% from price — treat as indicative; check FCF normalization (lumpy/one-off cash flows)

Short-sell evaluation

🚫 AVOID SHORTING

Despite a legitimate structural bear thesis (AI disruption of the FTE model, decelerating bookings, and forward demand destruction that the value crowd may be underweighting), this is a poor short at $129. The stock has already fallen ~50% and trades at ~10x earnings / 7.3x FCF with the market pricing in ~-10% perpetual FCF decline — much of the disruption thesis is already in the price, leaving asymmetric squeeze risk. The company carries a fortress net-cash balance sheet ($9.6B), generates $10.9B of clean FCF, returns $9.5B+ to holders, and the forensic short-seller found no accounting red flags (OCF and FCF both exceed net income). Shorting a debt-free, high-FCF quality franchise already at trough multiples, into deeply bearish sentiment and heavy buybacks, is the classic setup for a violent squeeze if the disruption fear proves cyclical.

Pros (the short could work)

AI/LLM structural displacement of FTE consulting could permanently impair the earnings base — a genuine secular decline thesis
Decelerating fundamentals: bookings -2-3% LCY, consulting low-single-digit, managed services deals slipping to FY27, guidance range widened downward
Negative price momentum and institutional distribution (Truist PT cut, unusual put/call activity) confirm the tape
$9B M&A acceleration risks goodwill impairments and margin dilution if OT cybersecurity integrations disappoint
Hyperscaler competition (Microsoft Copilot, AWS, Google) directly encircles the managed services delivery layer

Cons (what kills the short)

Already down ~50% at ~10x P/E / 7.3x P/FCF — disruption fear is substantially priced in; poor risk/reward for new shorts
Fortress balance sheet: $9.6B net cash, no debt, $10.9B clean FCF — no financing fragility to force a collapse
Aggressive buybacks ($9.5B+ returns) plus deeply bearish sentiment create acute short-squeeze risk
No accounting red flags (forensic short-seller PASS 72): OCF and FCF both exceed net income, clean earnings quality
Durable moat (195/200 top clients 10+ years, 26% ROIC) means the median outcome is slow growth + re-rating, not zeroing out — unlimited-downside asymmetry against the short

Council scorecard

Lens	School	Stance	Score	Conf
Valuation Referee (Damodaran-style)	referee	🟢 pass	82	high
Joel Greenblatt	value	🟢 pass	78	medium
Charlie Munger	quality	🟢 pass	78	medium
Warren Buffett	quality	🟢 pass	76	medium
Bruce Greenwald	value	🟢 pass	76	medium
Howard Marks	risk	🟢 pass	74	medium
Michael Mauboussin	quality	🟢 pass	74	medium
Benjamin Graham	value	🟢 pass	72	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟢 pass	72	medium
Chuck Akre	quality	🟡 watch	62	medium
Terry Smith (Fundsmith)	quality	🟡 watch	62	medium
Ray Dalio	risk	🟡 watch	52	medium
Philip Fisher	growth	🟡 watch	52	medium
Seth Klarman	value	🟡 watch	52	medium
Peter Lynch	growth	🟡 watch	52	high
AI & Disruption Referee (Christensen-style)	referee	🟡 watch	48	medium
Stanley Druckenmiller	risk	🔴 avoid	28	high
Walter Schloss	value	🔴 avoid	22	high

Member reasoning

Valuation Referee (Damodaran-style) — 🟢 pass · 82/100 · high confidence

Accenture is a textbook Damodaran-style valuation case: stable, large-cap, asset-light professional services with predictable FCF, a decade of operating history, and enough disclosed financials to build a credible story-to-numbers DCF. The two-stage DCF provided (base intrinsic $261.37 vs. current price $128.98) implies ~103% upside at base, with even the bear case ($215.24) sitting 67% above the current price. I need to interrogate the assumptions critically before accepting that margin of safety. The DCF uses a 4.19% FCF growth rate (revenue CAGR anchor), a 10.13% WACC, and 2.5% terminal growth. Let me assess each: (1) WACC of 10.13% using beta 1.17 is defensible — Accenture is a global IT services firm with moderate operating leverage; beta near 1.17 is reasonable, and with essentially zero net debt (net cash $9.65B), the all-equity cost of capital approach is appropriate. Not torturing the discount rate downward. (2) FCF growth at 4.19% (revenue CAGR) is actually conservative given historical FCF: $8.4B (2021) → $10.9B (2025), a CAGR closer to 6.7%. The model actually understates historical FCF growth. Using 4.19% is a genuinely conservative anchor — not a heroic assumption. (3) Terminal growth at 2.5% is at or just above long-run nominal GDP; for a global firm with multi-currency exposure this is borderline aggressive but defensible. A 2.0% terminal rate is safer; sensitivity shows bear case still $215. (4) ROIC of 26.2% vs. WACC of ~10.1% = spread of ~16 percentage points — this is exceptional value creation, and the reinvestment rate is modest (capex only $600M on $69.7B revenue), reflecting the people/acquisition model. Acquisitions ($9B this year alone) are the real reinvestment; historical acquisition integration has been accretive (revenue CAGR 4.2% ex-FY22 spike). The implied expectations reverse-engineering is telling: at $128.98, the market is pricing in negative FCF growth (~-9.8% annually per @Dividendology, corroborated by DCF math). For this to be fair value, Accenture would need to see persistent, structural revenue decline — possible in a scenario where AI agents eliminate FTE consulting demand entirely, but this is a severe bear scenario, not a base case. The business generated $10.9B FCF in FY2025, guided $10.8-11.5B for FY2026, has 195 of top 200 clients with 10+ year relationships, is actively shifting to software/platform revenue (Dragos ARR $208M at 48% growth), and has a net cash balance sheet. Operating margin expanded +20bps YoY despite heavy reinvestment. The key narrative-to-numbers risk is AI structural disruption of FTE consulting — real but unlikely to manifest as the near-total demand destruction the current price implies. The Q3 FY2026 headwinds (Middle East $100M, federal drag, managed services timing) are real but transient in nature relative to the FCF base. The stock trading at 52-week highs ($307) just months ago at $129 with fundamentals essentially intact suggests market sentiment dislocation rather than fundamental impairment. At price-to-FCF of 7.26x and P/E of 10.3x on a business with 26% ROIC and positive FCF growth, the margin of safety is substantial even under conservative inputs. The investment does not require the optimistic scenario — it works on base and even survives a meaningful compression in growth assumptions.

Key points

DCF intrinsic value $261 base / $215 bear vs. $129 price — margin of safety holds even at conservative inputs without requiring heroic assumptions
WACC of 10.13% using beta 1.17 is internally consistent and not manipulated downward; all-equity cost of capital appropriate given net cash position of $9.65B
FCF growth assumption of 4.19% is actually below historical FCF CAGR of ~6.7% (2021-2025), making the model conservatively anchored
ROIC of 26.2% massively exceeds WACC (~10.1%), so incremental growth creates substantial value — this is not value-destructive growth dressed as a story
Price-to-FCF of 7.26x and P/E of 10.3x imply the market is pricing in persistent structural decline (~-9.8% FCF annually) that requires near-total AI displacement of consulting to justify
Terminal growth at 2.5% is the weakest link — a 2.0% assumption reduces intrinsic value but bear case DCF ($215) still provides 67% upside
Non-FTE revenue shift (Dragos $208M ARR at 48% growth, mid-market Edge launch) provides plausible story-to-numbers path for margin mix improvement beyond base case
Capital returns ($9.5B+ in FY2026 including buybacks + dividends at ~7% yield on market cap) provide cash-flow-based floor support

Red flags

Terminal growth at 2.5% slightly above long-run nominal GDP for a mature business — should arguably be 2.0%; reduces intrinsic value modestly but doesn't break the thesis
$9B acquisition spend this year is elevated — integration execution risk on OT cybersecurity platform (Dragos+RunZero+NetRise) could impair FCF if synergies disappoint; acquisition ROIC not independently verifiable from filing excerpts
Revenue CAGR of 4.19% over 3 years is modest and slowing — if AI structurally compresses consulting demand below that rate, the FCF growth anchor erodes
DCF caveat flagged by model: >100% divergence from price warrants FCF normalization check — FY2025 FCF of $10.87B appears genuine (operating CF $11.47B - capex $600M) with no obvious one-off inflation, but lumpy acquisition years can distort
Guidance range widening ('more of the range is in play') and Truist PT cut signal near-term earnings risk; if FY2026 EPS tracks to $13.78 floor, the earnings base used in DCF projections may be slightly optimistic
Price data anomaly: fact base shows last_close $128.98 = 52w_high and 52w_low = $118.15 while fundamentals show 52w_high $307.77 — data inconsistency suggests possible stale/split price feed; thesis holds but price input should be verified

Joel Greenblatt — 🟢 pass · 78/100 · medium confidence

Accenture passes the Magic Formula dual test reasonably well at current prices. On the earnings yield axis: EBIT was $10.23B (FY2025). Market cap is ~$78.9B. Debt appears minimal (debt-to-equity is null/not reported, cash is $9.65B), so EV ≈ $78.9B - $9.65B excess cash = ~$69.3B (conservative; I'll use ~$72B allowing for some lease/minority interest). EBIT/EV ≈ $10.23B / $72B ≈ 14.2% earnings yield — that is genuinely high for a quality large-cap. On the ROIC axis: operating income $10.23B on a tangible capital base of (net working capital + net fixed assets). Net working capital = current assets $28.1B - current liabilities $19.9B = ~$8.2B; fixed assets (capex is only $600M, suggesting a primarily intangible/people business with very low net PP&E — likely under $3B). So Greenblatt ROIC denominator is roughly $10-12B, implying EBIT/tangible capital of ~85-100%+. This is an extraordinarily asset-light, high-ROIC business by the Magic Formula definition. The combination — ~14% earnings yield AND very high tangible-capital ROIC — scores well on both axes simultaneously, which is precisely the Magic Formula sweet spot. The stock is down ~50% YTD (52-week high $307.77 vs. current $128.98), reflecting a genuine earnings-multiple compression, not a deterioration in the underlying capital economics. FCF of $10.87B vs. net income of $7.68B shows strong cash conversion (FCF > net income, a very good sign). The P/E of ~10x on this quality of business is historically cheap. The DCF intrinsic value of $261/share (base) implies ~100% upside — even the bear case ($215) is 67% above current price. Caveats keeping me from a higher score: (1) The earnings yield is solid but not extreme once you accept that intangibles (goodwill from $9B M&A this year) are growing and the Greenblatt formula works best on tangible capital — inflating denominator with goodwill would compress ROIC to still-good but less spectacular ~26% ROIC (matching the reported figure). (2) Near-term earnings risk is real — guidance was cut, Middle East headwind, federal drag, managed services timing — so normalized EBIT may be somewhat below FY2025's $10.23B level. (3) No special-situation catalyst here; this is a pure Magic Formula quality-at-a-discount play, which still qualifies but lacks the extra mispricing layer of a spinoff or restructuring. (4) The $9B M&A deployment this year is heavy and could impair capital efficiency if integrations disappoint. Overall: a high-quality, asset-light compounder at a genuinely cheap earnings yield — exactly the type of situation the Magic Formula was designed to surface.

Key points

EBIT/EV earnings yield ~14%: strong by Magic Formula standards for a large-cap quality business
Tangible ROIC extremely high (85-100%+ on net working capital + net PP&E) given asset-light consulting model
FCF of $10.87B exceeds net income of $7.68B — clean, repeatable cash earnings with strong conversion
Stock at $129 vs. 52-week high of $307.77 — ~58% off peak; valuation compression appears sentiment-driven not fundamental
P/E of ~10x on $7.68B net income; price-to-FCF of 7.26x is exceptionally cheap for this quality tier
Reported ROIC 26.17% even on the accounting equity base — confirms high-return business quality
DCF base case $261/share implies ~100% upside; even bear case $215 is 67% above current price
Client relationships durable: 195 of top 200 clients >10 years; 104 clients with $100M+ bookings YTD

Red flags

Near-term EBIT at risk: guidance widened downward, Middle East impact ($100M), federal headwind (~1.5%), managed services timing slippage — normalized EBIT may be 5-10% below FY25 level
$9B M&A deployment this year (Dragos, RunZero, NetRise, Alpha Health) adds goodwill to balance sheet, diluting tangible ROIC and introducing integration execution risk
No special-situation catalyst — this is purely a valuation-compression/Magic Formula play without a spinoff or restructuring trigger to force price realization on any timeline
Revenue CAGR only 4.2% over 3 years — not a growth engine; Magic Formula works best when the cheap, high-ROIC business can also reinvest at high returns, which is constrained here by organic growth rate
Retail sentiment weak and bearish; options market showing unusual put/call activity — sentiment momentum against the stock near-term
AI disruption risk to consulting FTE model is structurally real, even if management is proactively pivoting; market is pricing meaningful probability of consulting revenue impairment

Charlie Munger — 🟢 pass · 78/100 · medium confidence

Accenture is squarely within my circle of competence — it is a professional services and technology firm with a decades-long track record, understandable economics, and clear sources of competitive advantage. I can explain the business model in a paragraph: large enterprises pay Accenture to design, implement, and manage complex technology and business transformation programs; Accenture's moat derives from deep client relationships (195 of top 200 clients for 10+ years), proprietary methodologies, scale advantages in talent and global delivery, and high switching costs on large multi-year managed services engagements. The current price presents a genuinely interesting quality-at-a-fair-price opportunity — not a deep value trap. ROIC of 26% and ROE of 25% are exceptional and sustained across the full history shown (2021-2025). FCF margins have been consistently in the 13-16% range. The business generates real cash — $10.9B FCF in FY2025 against $7.7B net income, a 1.42x conversion ratio that confirms clean accounting. Operating margins have expanded 8 consecutive quarters per news sources. At ~$129, the stock trades at roughly 7.3x price-to-FCF and 10.3x PE — multiples I have not seen on a business of this quality in my career. The DCF intrinsic value of $261 (bear case $215) implies roughly 100% upside even under conservative assumptions. That said, the near-term environment introduces genuine uncertainty: a ~50% YTD price decline reflects real concerns about AI-driven disruption of the consulting model, a $100M Middle East headwind, federal business drag, and management widening its guidance range. I weigh these carefully. The bear thesis — AI agents commoditize FTE consulting and compress margins structurally — is plausible but not yet evidenced in the financials; margins are actually expanding. Management's capital allocation has been rational: 10% dividend raise, aggressive buybacks, and M&A focused on cybersecurity platforms with recurring revenue. The $9B M&A deployment this year is aggressive and introduces integration risk. Still, the business passes my inversion test: I cannot identify a credible path to permanent capital impairment for a firm with $9.6B cash, no net debt, $10.9B annual FCF, and 798,000 employees serving clients who have been with them for over a decade. The price, while not a gift at the 52-week high of $307, is fair to cheap for this quality of franchise.

Key points

ROIC of 26.2% and ROE of 24.9% — consistently above 15% threshold across full history; this is a genuinely high-quality business by any sensible measure
FCF of $10.9B vs net income of $7.7B — 1.42x conversion confirms earnings quality and conservative accounting; no non-GAAP sleight of hand visible in the cash flow statement
Price-to-FCF of 7.3x and PE of 10.3x represent a meaningful discount to quality; DCF intrinsic value of $261 (bear $215) implies significant margin of safety at $129
Moat is identifiable and durable: 195 of top 200 clients retained 10+ years; 104 clients with $100M+ quarterly bookings up 13% YoY; high switching costs on managed services contracts spanning years
Management capital allocation is owner-minded: 10% dividend raise, $9.5B+ returned to shareholders, buybacks reducing share count; balance sheet has $9.6B cash and no net debt
AI as tailwind not just headwind: 100 new clients initiating advanced AI projects this quarter; bookings from top AI partners tracking 2x FY25; OT cybersecurity acquisitions (Dragos at $208M ARR, 48% growth) represent a credible non-FTE revenue mix shift
Operating margins expanding 8 consecutive quarters despite heavy reinvestment (124K promotions, 30% increase); management delivering on margin commitments

Red flags

AI disruption risk to the core FTE consulting model is the central bear thesis and deserves respect — if clients build in-house AI capabilities or shift to agent-based automation, headcount-linked revenue could compress structurally; this is not yet in the financials but bears watching
Management widened guidance range mid-year ('more of the range is in play') — a candor credit but also signals lower visibility; near-term earnings risk to the downside is real
$9B M&A deployment this year (Dragos, RunZero, NetRise, Alpha Health) is a step-change from $5B guided; integration risk on multiple simultaneous cybersecurity platform acquisitions, all at likely premium valuations in a hot sector
Federal business drag (~1.5% Americas headwind) and Middle East consulting impact ($100M) may persist longer than management expects; Accenture has meaningful government exposure that adds political/policy risk
Managed services deal slippage to FY27 for 'company-specific reasons' — vague disclosure; if more deals push out, near-term bookings and revenue recognition could disappoint
Stock has declined ~50% YTD, suggesting the market has significant concerns that the financial statements may not yet fully reflect; sentiment fragility and analyst downgrades (Truist PT cut) add near-term risk
Revenue CAGR of only 4.2% over 3 years is modest for a business of this scale; if AI-driven disruption accelerates, even this growth rate may prove optimistic

Warren Buffett — 🟢 pass · 76/100 · medium confidence

Accenture is a high-quality professional services franchise that sits within my circle of competence — it earns its returns through human expertise, client relationships, and switching costs rather than opaque technology. The economics are straightforward: sell consulting and managed services to large enterprises, generate fat free cash flow, return it to shareholders. At ~$129, this appears to be a wonderful business at a genuinely fair — perhaps cheap — price, though near-term earnings visibility has deteriorated meaningfully. The moat is real but under stress, which keeps my conviction from being higher. Let me work through my criteria systematically. MOAT: Accenture's castle is built on deep client relationships (195 of top 200 clients for 10+ years), significant switching costs (multi-year transformation programs embedded in client operations), and a global talent and delivery network that is extraordinarily difficult to replicate. These are genuine moat characteristics. The 104 clients with $100M+ quarterly bookings, up 13% YoY, demonstrates sticky, deepening relationships. However, the AI disruption narrative is not noise — there is a real question about whether LLMs and AI agents erode the FTE-intensive consulting model over a 5-10 year horizon. This is the central moat question I cannot fully resolve. RETURNS ON CAPITAL: ROIC of 26.2% and ROE of 24.9% are excellent and sustained across the 5-year history shown. FCF margins of 13-16% on $70B revenue are consistent and strong. Net income converts reliably to free cash — FCF of $10.87B vs. net income of $7.68B in FY2025 shows strong owner earnings (the D&A cushion). Capex is minimal at $600M on $70B revenue, confirming this is asset-light. These are Berkshire-quality return metrics. BALANCE SHEET: Debt-to-equity shown as null, but cash of $9.6B vs. modest capex suggests a pristine balance sheet. Current ratio 1.41. No leverage concerns. The business self-funds through any reasonable downturn. MANAGEMENT & CAPITAL ALLOCATION: The 10% dividend increase, $9.5B+ in shareholder returns, and transparent earnings call communication (candid about Middle East drag, managed services timing) signal honest management. However, the $9B M&A deployment this year — up from $5B guided — warrants scrutiny. Dragos at a high multiple for $208M ARR feels like empire-building risk. Historically Accenture has integrated acquisitions well, but the pace and scale of this pivot toward software/platform assets is new territory. The buyback authorization is noted, but I need to know they're buying at prices below intrinsic value — at these levels, the DCF suggests they are. VALUATION: At $129 vs. DCF intrinsic of $261 (base case), the stock appears to offer roughly 100% upside — a significant margin of safety if FCF assumptions hold. Price-to-FCF of 7.26x on $10.87B FCF is strikingly low for a business of this quality. P/E of 10.3x and price-to-sales of 1.13x are deep-value metrics for a company with 26% ROIC. The 50% YTD decline is the market pricing in structural impairment of the consulting model. I think the market is right to be concerned but wrong to price in near-permanent deterioration. The WACC of 10.1% seems reasonable; the 4.2% FCF growth assumption (revenue CAGR) is conservative. Even the bear DCF of $215 implies 67% upside from current price. RISKS KEEPING SCORE FROM 85+: (1) AI displacement of FTE consulting is a genuine multi-year risk I cannot quantify with confidence — this is the moat question; (2) Guidance range widening ('more of the range is in play') signals low near-term visibility; (3) $9B M&A at elevated cybersecurity multiples creates integration and return-on-capital risk; (4) Revenue growth at only 4.2% CAGR is modest for a business of this scale and quality; (5) Federal business drag and geopolitical headwinds add uncertainty. BOTTOM LINE: This passes my bar as a wonderful business at a fair-to-cheap price, with the critical caveat that the moat is under the most meaningful competitive challenge in Accenture's history. I would want to own a position, not a full allocation, and monitor whether the AI displacement thesis plays out in revenue share losses or merely in near-term discretionary budget cuts.

Key points

ROIC 26.2% and ROE 24.9% sustained over 5 years — elite capital efficiency without leverage
Asset-light economics: $600M capex on $70B revenue; FCF of $10.87B exceeds net income of $7.68B confirming strong owner earnings
195 of top 200 clients retained 10+ years; 104 clients with $100M+ quarterly bookings (+13% YoY) evidencing deep switching costs
Price-to-FCF of 7.26x and P/E of 10.3x represent significant discount to intrinsic value; DCF base case ~$261 vs $129 price
Honest management: candid about headwinds on earnings call, 10% dividend increase, $9.5B+ shareholder returns committed
Conservative balance sheet: $9.6B cash, minimal debt, self-funding through downturns
Mid-market expansion (Accenture Edge) and OT cybersecurity platforms add TAM without requiring massive capital deployment
Revenue CAGR of 4.2% is modest but stable; margins expanding (+20bps YoY) despite heavy reinvestment

Red flags

AI/LLM disruption of FTE-intensive consulting model is the central moat threat — structurally harder to dismiss than typical competitive noise
$9B M&A this year vs $5B guided represents aggressive empire-building in cybersecurity; integration risk elevated
Guidance range widening ('more of the range is in play') signals low near-term earnings visibility — I prefer predictable owner earnings
Book-to-bill at 1.0 and consulting in low single-digit growth suggests demand softness, not just timing
Federal business headwind and Middle East drag both structural in near-term; no clear resolution timeline
50% YTD stock decline means the market has already voted against the moat durability thesis — not to be dismissed entirely
Revenue growth at 4.2% CAGR is relatively pedestrian for the quality of returns generated; scale may be limiting future compounding

Bruce Greenwald — 🟢 pass · 76/100 · medium confidence

Accenture qualifies for EPV analysis as a large, mature professional-services franchise with a long earnings history. The key EPV question: does normalized earnings power support the current $129 price, and is there evidence of a real franchise (EPV >> reproduction value)?

EPV Calculation: Using FY2025 operating income of $10.23B and a 5-year average operating margin of ~14.7% applied to FY2025 revenue of $69.7B gives normalized EBIT of ~$10.2B. Tax-affect at ~22% (consistent with reported net margin ~11% vs. operating margin ~14.7%): NOPAT ≈ $7.96B. Maintenance capex vs. D&A: capex is only $600M against presumably higher D&A (exact D&A not isolated in the fact base, but FCF = $10.87B on operating cash flow of $11.47B implies capex ~$600M; Accenture is asset-light so D&A likely modest and close to maintenance capex — minimal adjustment needed). FCF is $10.87B, which is actually higher than NOPAT due to working capital dynamics in a services firm. I'll use distributable earnings closer to NOPAT ≈ $7.9–8.0B as the conservative normalized figure. Capitalizing at WACC of ~10.1%: EPV ≈ $7.96B / 0.101 = ~$78.8B enterprise value. Add net cash of ~$9.65B: equity EPV ≈ $88.5B. With 637M shares, EPV per share ≈ $139. Current price is $129, implying a ~8% discount to EPV — a thin but genuine margin of safety on the no-growth base case.

Moat Test (EPV vs. Reproduction Value): Reproducing Accenture's asset base is extremely costly. Tangible assets are modest (~$64.7B total assets but heavily current assets and goodwill from acquisitions). The real reproduction cost lies in intangibles: rebuilding relationships with 195 of the world's top 200 companies (10+ year tenures), 800K trained consultants, top-tier brand recognition, and embedded delivery infrastructure would likely cost tens of billions and take a decade. ROIC of 26.2% is far above WACC of ~10%, strongly suggesting the EPV >> reproduction value condition that signals a real franchise. The barriers are concrete: (1) customer captivity via deep embedding in mission-critical processes (ERP, supply chain, managed services) creating high switching costs; (2) economies of scale in global delivery centers; (3) proprietary AI/platform assets being built out (though these are nascent). The 104 clients with $100M+ quarterly bookings and 13% YoY increase confirms captive, recurring large-client relationships.

Margin of Safety Assessment: At $129, price is ~7% below my conservative EPV of ~$139/share. That is a thin margin of safety by Greenwald standards — I would prefer 20–30%. However, three factors push me toward 'pass' rather than 'watch': (1) the EPV is deliberately normalized with NO growth credit — any organic growth at above-WACC returns (ROIC 26% suggests this is structural, not cyclical) makes the EPV conservative; (2) the 50% YTD stock decline has compressed the price to a level where EPV is now roughly at parity with market price, a rare condition for a franchise of this quality; (3) the balance sheet is net-cash positive ($9.65B), providing additional asset floor support.

Key Risk to EPV: The bear case centers on structural AI disruption reducing the number of FTEs needed for consulting, which would compress normalized earnings. If operating margins revert from 14.7% to, say, 12%, NOPAT falls to ~$6.5B and EPV per share drops to ~$113 — below the current price. This is the critical uncertainty that prevents a higher-confidence 'pass.' Management's pivot toward non-FTE revenue (Dragos ARR, platform models) is the right strategic response but is unproven at scale. The $9B M&A deployment also introduces execution risk that could depress near-term distributable earnings.

On the provided DCF: The model's $261 intrinsic value relies heavily on terminal value (70.6% of enterprise value) and ~4.2% perpetual FCF growth. Per my methodology, I largely discount this — the terminal value arithmetic is where errors hide. My EPV at $139 is more reliable precisely because it assumes zero growth.

Verdict: ACN at $129 is modestly below EPV for a genuine franchise. The thin margin of safety and AI disruption risk justify a 'pass' rather than a conviction buy — this is a franchise at fair-to-slightly-cheap, not a deep-value bargain.

Key points

EPV per share estimated at ~$139 (NOPAT ~$7.96B / WACC 10.1% + net cash $9.65B / 637M shares), putting the stock ~7% below the no-growth intrinsic value
ROIC of 26.2% vs. WACC of ~10.1% confirms EPV >> reproduction value — a genuine franchise with customer captivity and scale barriers
195 of top 200 global clients with 10+ year tenures and 104 clients at $100M+ quarterly bookings represent concrete, high-switching-cost captive relationships
Asset-light model (capex only $600M on $70B revenue) means minimal maintenance capex drag; FCF conversion of 156% of net income is structurally high
Net cash of $9.65B provides asset floor; no debt-to-equity reported, balance sheet conservative
50% YTD price decline has compressed valuation to near EPV parity — rare for a franchise of this quality

Red flags

Thin margin of safety: EPV ~$139 vs. price $129 is only ~8% discount — Greenwald methodology prefers 20–30% minimum buffer
AI disruption risk to FTE economics could structurally impair normalized operating margin; if margins compress from 14.7% to 12%, EPV per share falls to ~$113, below current price
$9B M&A deployment (Dragos, RunZero, NetRise, Alpha Health) introduces execution risk and may depress near-term distributable earnings without immediate EPV accretion
Revenue CAGR of only 4.2% over 3 years — organic growth tepid; reliance on acquisitions to sustain earnings power is a risk if integration underperforms
Guidance language ('more of the range is in play') and Truist PT cut signal near-term earnings visibility is low, making normalization of current earnings uncertain
D&A vs. maintenance capex breakdown not fully isolated in fact base — EPV calculation assumes asset-light capex structure holds; if intangible amortization from acquisitions is large, true maintenance capex could be understated

Howard Marks — 🟢 pass · 74/100 · medium confidence

ACN has undergone a dramatic sentiment reset — stock down ~50% YTD, trading at ~10x PE versus historical multiples 65%+ higher — that is the kind of fear-driven, forced repricing I look for. The key question is whether this is a genuine discount to intrinsic value or a rational repricing of structurally impaired earnings. My read is the former, though with meaningful caveats. The DCF intrinsic value of $261/share (bear case $215) against a $129 price represents a 103% implied upside — even if I haircut the DCF assumptions aggressively, the margin of safety looks real. The balance sheet is clean: no material debt (debt-to-equity listed as null, implying near-zero net debt; cash $9.6B vs. operating cash flow $11.5B), current ratio 1.41, and FCF conversion strong (FCF $10.9B on net income $7.7B, implying 1.4x FCF/net income, a sign of quality earnings). The consensus has already repriced for catastrophe — 10x PE, 7.3x price-to-FCF, 1.1x price-to-sales for a business generating 15.6% FCF margins. The market is pricing in roughly -10% FCF growth annually per the Dividendology calculation cited in discussions. That is priced-for-disaster territory for a business with 195 of its top 200 clients retained over 10+ years, $19.3B quarterly bookings, and 9% EPS growth in the most recent quarter. Second-level thinking: the crowd believes AI agents will hollow out consulting headcount demand and structurally compress margins. This is a plausible first-level fear, but it ignores that Accenture is the integrator of AI transformation — the entity most likely to benefit from enterprise AI adoption complexity, not the entity displaced by it. The Dragos acquisition (48% ARR growth) and Accenture Edge mid-market launch suggest management is actively pivoting away from pure FTE risk. That said, I do not dismiss the structural risk — the guidance range is widening, consulting growth is in low single digits, and Middle East/federal headwinds add near-term uncertainty. These keep me from a higher score. Sentiment is revulsion-level (unusual options activity, Truist price target cuts, retail fear dominating), which historically marks better entry points than the reverse. The asymmetry here favors the buyer: downside is a business that earns $10B+ FCF annually at current run-rate, with no leverage; upside is a re-rating as AI-driven transformation demand recovers and the mid-market/cybersecurity pivots gain traction.

Key points

Stock down ~50% YTD creating extreme sentiment dislocation — retail sentiment dominantly bearish, unusual put/call activity, Truist PT cut post-earnings — classic capitulation signal
Balance sheet is fortress-level: net cash position (~$9.6B cash, debt-to-equity null/negligible), $10.9B FCF, 1.41 current ratio — no structural fragility or refinancing risk
Price-to-FCF of 7.3x and PE of 10.3x embed severe pessimism; market implying ~-10% FCF CAGR over the decade per retail calculation — an extremely low bar for a business with stable $10B+ FCF
DCF intrinsic value $261 (base) vs $129 price = 103% upside; even bear case ($215) implies 67% upside — wide margin of safety even with haircut assumptions
Second-level insight: consensus fears AI disrupting ACN's consulting model, but ACN is the primary enterprise AI integrator — complexity of AI deployment favors firms like ACN, not replaces them
Capital returns aggressive ($9.5B+ shareholder returns in FY26 including 10% dividend raise) and management deploying $9B in M&A for non-FTE revenue streams (Dragos ARR $208M at 48% growth) — signals confidence from insiders
Client retention durable: 195/200 top clients >10 years; 104 clients with $100M+ quarterly bookings YTD (+13% YoY) — moat is real despite near-term softness
Revenue CAGR 4.2% over 3 years; FCF margin 15.6% in FY2025 (recovery from FY2024 trough); operating margin expanding +20bps YoY — underlying business is not impaired

Red flags

Guidance range widening — management said 'more of the range is in play'; consulting growth in low single digits for FY26 signals real near-term demand softness, not just noise
Middle East conflict ($100M revenue drag) and federal business headwinds (~1.5% Americas impact) are unresolved and could extend into FY27; no clear resolution timeline
Managed services deal slippage to FY27 ('company-specific reasons') is opaque — magnitude and recoverability are genuinely uncertain; this is not a clean outlook
$9B M&A in a single year (Dragos, RunZero, NetRise, Alpha Health, Whaler) is a significant integration burden; OT cybersecurity platforms are small ($208M ARR) relative to $70B revenue base — synergy realization timeline is long
AI structural disruption risk to FTE consulting model is a legitimate secular question — not fully answered by management's pivot narrative; execution risk on Accenture Edge (unproven, just launching) is real
DCF residual value is 70.6% of total value — heavily dependent on terminal assumptions; if FCF growth disappoints materially, intrinsic value compresses sharply
Revenue CAGR of only 4.2% over 3 years is modest for a business historically rewarded as a growth compounder; re-rating requires visible acceleration that is not yet in the numbers

Michael Mauboussin — 🟢 pass · 74/100 · medium confidence

Accenture presents a compelling expectations-investing case: the stock has crashed ~50% YTD to ~$129, embedding deeply pessimistic assumptions that appear to price in sustained earnings deterioration inconsistent with the actual operating data. Let me work through the framework systematically.

ROIC vs. WACC Scorecard: ROIC of 26.2% against a WACC of ~10.1% produces a spread of ~+1,600 bps — exceptionally wide for a professional services firm. ROE of 24.9% is similarly elevated. FCF margin of 15.6% on $69.7B revenue is remarkable capital efficiency for a labor-intensive business. The spread has been durable across the 5-year history shown (FCF margins 13–17% range, never negative). This is not a thin-spread business where mean reversion is imminent — the question is trajectory.

Moat Assessment (Concrete, Not Adjective):

Switching Costs (Wide): 195 of top 200 clients have relationships >10 years. Multi-year managed services and transformation programs create deep procedural, relational, and financial exit costs. Clients running core operations on Accenture-managed infrastructure face enormous switching friction. This is the primary moat source — high, durable, evidenced by client concentration and longevity.
Scale Economies (Narrow-to-Wide): $70B revenue base enables unique investment in proprietary AI tools, training infrastructure (124K promotions, 900+ MDs), and ecosystem relationships (OpenAI, NVIDIA, Anthropic, Databricks, Snowflake at 2x bookings YoY). No PE-backed or regional competitor can match this investment capacity. However, per-FTE economics are largely commodity unless Accenture can shift to non-FTE models.
Network Effects (None-to-Narrow): Limited direct network effects in traditional consulting. The ecosystem model (top-10 AI partner bookings, Avanade JV) is an indirect platform effect in early development. Not a primary moat driver today.
Intangibles (Narrow): Brand is real but not a pricing-power moat in the classical sense — clients negotiate hard. The moat from intangibles comes from proprietary IP in delivery methodology and the talent/culture flywheel.
Moat Trajectory: Eroding at the margin (consulting FTE model) but potentially re-widening via non-FTE platform acquisitions (Dragos at $208M ARR/48% growth, Alpha Health, Accenture Edge). The strategic bet is whether the platform shift succeeds faster than consulting margin compresses. This is the key uncertainty.

Reading the Expectations in the Price: At $129 and ~$10.87B FCF (FY25 actual), price-to-FCF of ~7.3x is extraordinarily low for a business generating 26% ROIC. The DCF base case implies intrinsic value of $261 — a 103% discount. Even the bear case ($215) implies ~67% upside. The retail Dividendology comment — market pricing -9.8% FCF growth annually — is directionally correct and represents a deeply pessimistic distribution anchor.

What has to be true for the bear case? FCF must decline persistently and materially — either through major consulting revenue loss (AI displacing FTEs), margin compression from competitive pricing, or both. At 7x FCF, the market is pricing in meaningful structural impairment, not a cyclical trough.

Distribution of Outcomes (Outside View First): Base rate: Professional services firms with >25% ROIC, diversified geographies, and 10+ year average client tenure rarely experience the kind of structural margin collapse implied by current pricing. The median outcome for such firms is slow growth + multiple compression, not zero-ing out. The AI disruption bear case is legitimate but historically, technology displacing consulting has more often increased demand for integration expertise. Inside view adjustments: (1) Federal headwind is real but cyclical; (2) Middle East drag is transient geopolitical noise; (3) Managed services deal slippage is timing, not cancellation; (4) AI transformation work is growing (100 new clients this quarter, $19.3B book-to-bill 1.0). The earnings profile ($13.78–$13.90 guided EPS, 7–8% growth) is not collapsing — it is moderating.

Fat tails: (Upside) Mid-market Edge succeeds, Dragos scales, AI reinvention accelerates bookings — stock re-rates toward historical 25–30x PE. (Downside) AI genuinely hollows out managed services demand; federal business doesn't recover; OT cybersecurity acquisitions are overpriced and dilute ROIC — stock treads water at 8–10x.

Capital Allocation Quality: M&A at $9B this year is elevated but strategically coherent — shifting toward recurring software revenue (Dragos ARR model) is exactly the right move to protect ROIC if FTE consulting faces headwinds. Buybacks at these prices at 7x FCF are highly accretive — this is disciplined capital allocation, not empire-building. 10% dividend increase signals management confidence. The risk is overpaying for cybersecurity assets (historically compressed post-close in software M&A), but Dragos growing 48% at $208M ARR suggests the price isn't absurd.

What Would Change My Mind (Disconfirming Tests):

ROIC falling below 20% for two consecutive years (spread narrowing materially)
Book-to-bill falling below 0.95 for two quarters (demand destruction confirmed)
Managed services margins compressing >200 bps without recovery (FTE cost structure not offsetting)
Accenture Edge showing minimal adoption in 12 months (mid-market strategy fails)
OT cybersecurity ARR growth decelerating materially post-acquisition (integration failure)

Caveats: Confidence is medium rather than high because: (1) the guidance widening language is a genuine red flag for near-term visibility; (2) the non-FTE platform shift is unproven at scale; (3) AI disruption to the consulting model is a real optionality against the thesis, not just noise; (4) the 50% YTD decline may reflect information the market has that the filings don't fully reveal. The DCF caveat about lumpy FCF is worth noting — FY25 FCF of $10.87B vs. FY24 of $8.6B is a 26% jump that warrants scrutiny for normalization.

Key points

ROIC of 26.2% vs WACC of ~10.1% produces a ~1,600 bps spread — wide, durable, and not near mean-reversion territory based on 5-year history
Switching costs are the primary moat: 195 of 200 top clients >10 years, multi-year managed services programs with deep procedural and financial exit costs
Price embeds deeply pessimistic expectations: 7.3x FCF implies market pricing sustained FCF decline of ~10% annually — inconsistent with Q3 FY26 actuals (3% LCY revenue growth, 9% EPS growth, $3.6B quarterly FCF)
Capital allocation is disciplined: buybacks at 7x FCF are highly accretive; Dragos acquisition (ARR $208M, +48% growth) strategically coherent as ROIC-protective non-FTE pivot
DCF base case $261/share (bear $215) implies 67–103% upside even with conservative 4.2% FCF growth and 10.1% WACC — margin of safety exists across distribution, not just at base
Outside view base rate: diversified professional services firms with >25% ROIC and >10-year client tenure rarely undergo structural impairment — cyclical trough is more likely median outcome

Red flags

Guidance widening language ('more of the range is in play') signals low forward visibility — bottom-end EPS scenario ($13.78) represents earnings risk
FY25 FCF of $10.87B vs FY24 of $8.61B is a 26% jump requiring normalization check — if elevated by working capital timing, DCF base FCF is overstated
AI disruption to FTE consulting model is a genuine tail risk: if autonomous agents reduce managed services demand, the moat mechanism (switching costs) erodes over a 3-5 year horizon
OT cybersecurity M&A ($9B deployed) at elevated valuations — integration risk and time-to-scale unclear; historically software M&A compresses post-close returns
Non-FTE platform revenue (Dragos, Alpha Health, Accenture Edge) is small relative to $70B FTE-driven base — transition speed may be too slow to offset consulting deceleration
Truist PT cut post-earnings and unusual options activity signals sell-side and market uncertainty about the forward earnings path

Benjamin Graham — 🟢 pass · 72/100 · medium confidence

Accenture presents a genuinely unusual Graham-compatible situation: a large, stable, highly profitable business now trading at a meaningful discount to conservative intrinsic value following a ~50% price collapse. The stock passes several of my quantitative criteria — trailing P/E of ~10x, strong and consistent earnings over multiple years, robust FCF generation, a reliable and growing dividend — but fails certain balance-sheet tests I hold dear, and the margin of safety, while real, rests heavily on DCF terminal value assumptions rather than net asset value. Let me be precise. The trailing P/E of 10.28x is comfortably within my defensive ceiling of 15x; the earnings yield of 14.76% is well above any reasonable high-grade bond yield, satisfying my earnings-yield-versus-bond-yield test. Price-to-sales of 1.13x and price-to-FCF of 7.26x are modest. The DCF intrinsic value per share is $261.37 against a price of $128.98 — a discount of roughly 51%, exceeding my one-third margin-of-safety threshold. Even the bear-case DCF of $215.24 implies 67% upside from current price. Earnings have been consistently positive and growing: net income rose from $5.9B (2021) to $7.7B (2025), FCF from $8.4B to $10.9B — no losses, no interruptions. The dividend has been raised 10% recently (quarterly $1.63/share) and is well covered by FCF. Accenture is emphatically not a speculative micro-cap; it is an established, globally diversified professional services firm with 195 of its top 200 clients retained for 10+ years. Where my criteria are NOT met: the current ratio of 1.41 falls short of my preferred 2.0 minimum, and the balance sheet, while technically solvent (equity $30.9B, cash $9.6B), does not pass my stringent net-net test — current assets of $28.1B do not cover total liabilities (approximately $33.8B estimated from assets minus equity). P/B of 2.56x combined with P/E of 10.28x gives a product of ~26.3, marginally exceeding my 22.5 rule of thumb. The debt-to-equity ratio is reported as null (possible goodwill/intangible structure from acquisitions), which is a data gap. I also note significant concern: management is deploying $9B in acquisitions this year, including OT cybersecurity platforms at high valuations, which is speculative capital allocation by my standards. The earnings trajectory faces genuine uncertainty from AI disruption of the consulting model, Middle East headwinds, and federal business drag. My confidence is medium because the DCF assumptions (4.19% FCF growth, 10.13% WACC, 2.5% terminal growth) are reasonable but the 70.6% residual value in terminal value is a classic weakness — I cannot verify intrinsic value from net current assets or hard book value alone. Nevertheless, Mr. Market has offered this business at a deep discount to any reasonable earnings-based valuation. For a defensive investor, this passes my bar at a modest score, with the caveat that balance-sheet purists should note the current ratio shortfall.

Key points

Trailing P/E of 10.28x is well below my 15x defensive ceiling; earnings yield of 14.76% handsomely exceeds high-grade bond yields
DCF intrinsic value $261.37 vs. price $128.98 — 51% discount exceeds my one-third margin-of-safety requirement; even bear-case DCF ($215.24) implies 67% upside
Consistent, uninterrupted earnings growth over 2021-2025: net income $5.9B → $7.7B, FCF $8.4B → $10.9B — no losses in the observable record
Dividend raised 10% to $1.63/quarter; well covered by $10.9B FCF; reliable dividend history satisfies my durability requirement
Adequate size and stability: $79B market cap, 798K+ employees, 195 of top-200 clients retained 10+ years — this is an established business, not speculation
Price-to-sales 1.13x and price-to-FCF 7.26x are genuinely modest for a business of this quality and stability

Red flags

Current ratio of 1.41 fails my preferred 2.0 minimum — balance sheet does not meet my strict working-capital test
P/E x P/B product of ~26.3 marginally exceeds my 22.5 rule of thumb, indicating modest asset richness
Debt-to-equity ratio reported as null — data gap; goodwill from acquisition-heavy strategy may overstate book equity
$9B M&A deployment this year (OT cybersecurity at high valuations) is speculative by my standards; integration risk unquantifiable from filings
70.6% of DCF value sits in terminal value — intrinsic value cannot be verified from hard net assets; margin of safety depends heavily on DCF assumptions
AI disruption of consulting model is a genuine secular threat to the earnings base that my historical earnings stability test cannot fully price in

Forensic Short-Seller (Chanos/Einhorn-style) — 🟢 pass · 72/100 · medium confidence

Accenture passes the forensic short-seller screen with no material accounting red flags. The core test — earnings vs. cash — is clean: operating cash flow of $11.47B comfortably exceeds net income of $7.68B in FY2025, implying a strong cash conversion ratio (~1.49x). FCF of $10.87B also exceeds net income, which is the opposite of the classic Chanos red flag. The accrual ratio (net income minus FCF divided by average assets) is negative, indicating earnings quality is high. However, the ~50% YTD price collapse warrants forensic attention, and several secondary flags merit scrutiny. The $9B M&A acceleration (Dragos, RunZero, NetRise, Alpha Health) introduces serial-acquirer risk: goodwill accumulation, integration opacity, and the risk that acquired ARR metrics are promotional. Guidance widening ('more of the range is in play') and managed services deal pushouts deserve working capital scrutiny. Share count trend requires checking — SBC is material at a firm of 798K+ employees, and buybacks may be partially treadmill. Overall, this is not a short candidate on accounting quality grounds, but the M&A acceleration and guidance opacity introduce a 'watch' element within a broader pass verdict.

Key points

FCF ($10.87B) materially exceeds net income ($7.68B) — cash conversion ratio ~1.49x is forensically clean; no accruals-masking-losses pattern
Operating cash flow ($11.47B) also exceeds net income — the core Chanos earnings-vs-cash test passes decisively
Balance sheet shows $9.6B cash, no debt-to-equity reported (low/no net debt), strong current ratio of 1.41 — no financing dependence or debt wall
Revenue has grown modestly but steadily (CAGR 4.2% over 3 years); no sign of aggressive revenue recognition or DSO blowout
ROIC of 26.2% and ROE of 24.9% are genuinely high for a services firm, not manufactured by leverage
$9B M&A deployment in FY26 (vs. $5B guided) is a serial-acquirer escalation — goodwill on balance sheet needs monitoring for future impairment risk
SBC dilution risk: with 798K employees and heavy promotion cycles, SBC as share of adjusted earnings not quantifiable from available data — share count trend not explicitly confirmed shrinking
Guidance language ('more of the range is in play') and managed services deal slippage are near-term transparency concerns

Red flags

Serial acquirer acceleration: $9B M&A in FY26 vs $5B guided — Dragos ($208M ARR at 48% growth) and three OT cybersecurity platforms create goodwill accumulation risk and integration opacity; promoted ARR metrics need independent verification
Guidance range widening to bottom-end is a classic management hedging signal — 'company-specific' managed services pushouts to FY27 are opaque and unverifiable from available data
SBC and dilution treadmill risk: buyback program returning $9.5B+ but actual share count reduction not confirmed; with 798K employees and 124K promotions/30% increase YoY, RSU/SBC dilution could be absorbing repurchase capital
Missing data: DSO trend, unbilled receivables, working capital detail, and goodwill/intangibles build from recent M&A not extractable from XBRL filing excerpts provided — limits confidence in full forensic pass
Stock down ~50% YTD while earnings guides are only mildly cut — market may be pricing in structural demand impairment (AI disruption of consulting FTE model) that is not yet visible in accruals but could materialize in future write-downs on capitalized M&A goodwill

Chuck Akre — 🟡 watch · 62/100 · medium confidence

Accenture is a genuine quality business with several Akre-worthy characteristics — high ROIC (26%), strong FCF conversion, durable client relationships, and a long operating history of compounding. However, the three-legged stool is wobbling: the reinvestment runway leg is clouded by existential questions about AI disruption to the core FTE-based consulting model, the management integrity leg is solid but capital allocation is under scrutiny with $9B in accelerated M&A deployment at elevated cybersecurity valuations, and the valuation leg — while superficially attractive at 10x PE and ~7x price-to-FCF — reflects genuine uncertainty about whether current earnings are a peak or a trough. The DCF intrinsic value of ~$261/share implies massive upside (103%) from $129, but the DCF's 4.2% growth assumption may be optimistic given structural headwinds, and the model's caveat about FCF normalization is warranted (FY25 FCF jumped to $10.9B from $8.6B in FY24, a normalization question). ROIC of 26% and ROE of 25% are excellent and achieved without leverage (null debt-to-equity, net cash position of ~$9.6B). FCF margin of 15.6% and operating margin of 14.7% confirm capital-light characteristics. Revenue CAGR of only 4.2% over 3 years is modest for a quality compounder at this valuation reset. The reinvestment runway question is the crux: Accenture's core moat — deploying 800K+ skilled workers at large enterprise clients — faces genuine disruption risk from AI agents. Management is pivoting (OT cybersecurity platforms, Accenture Edge mid-market, non-FTE commercial models) but these are early innings and small relative to the $70B base. Dragos ($208M ARR, 48% growth) is promising but tiny. The AI pivot is not yet proven as a reinvestment opportunity at the same high returns as the legacy business. Management (Julie Sweet) has been candid about headwinds — a positive integrity signal — but the $9B M&A acceleration in a single year at elevated cybersecurity valuations raises capital allocation discipline questions. The 50% YTD stock decline creates an interesting entry point, but for Akre-style investors, the reinvestment runway uncertainty is a gating issue. A quality business going through a structural transition, fairly priced for the uncertainty, warrants a watch rather than a pass until the AI-enabled reinvestment thesis is more demonstrable.

Key points

ROIC of 26.2% and ROE of 24.9% are strong, achieved with no balance sheet leverage and a net cash position (~$9.6B cash, null D/E) — genuine business economics not financial engineering
FCF conversion is excellent: $10.9B FCF vs $7.7B net income = 1.4x conversion ratio; price-to-FCF of 7.3x is cheap on an absolute basis for a quality franchise
195 of top 200 clients with 10+ year relationships and 104 clients with $100M+ quarterly bookings (+13% YoY) confirm deep switching costs and moat durability
DCF implies ~$261 intrinsic value vs $129 price — 103% upside — but growth assumptions (4.2% CAGR) are modest and the terminal value dominates (70.6% of enterprise value), making it sensitive to long-run assumptions
Management candor on near-term headwinds ('more of the range is in play') is an integrity positive; 10% dividend increase and $9.5B+ capital return commitment demonstrate shareholder orientation
Reinvestment runway is the key uncertainty: pivot to OT cybersecurity platforms, Accenture Edge mid-market, and non-FTE models is strategically sensible but unproven at scale relative to $70B base

Red flags

AI structural disruption to core FTE consulting model is the primary Akre-style risk — the reinvestment runway (the most important leg) may be shrinking if AI agents reduce headcount demand; not yet quantifiable but directionally negative
$9B M&A acceleration in a single year (vs $5B guided) into cybersecurity at elevated valuations (Dragos, RunZero, NetRise) raises capital allocation discipline concerns — Akre demands value-accretive acquisitions below intrinsic value
Revenue CAGR of only 4.2% over 3 years is insufficient compounding for a true Akre compounder; per-share FCF growth has been inconsistent (FCF ranged $8.6B-$10.9B, no steady upward trend)
Stock down 50% YTD signals market is re-underwriting the moat, not just macro noise; Truist PT cut post-earnings and unusual options activity suggest sell-side and sophisticated investors are reducing conviction
Accenture Edge and OT security platform are early-stage and unproven as high-ROIC reinvestment vectors — management's reinvestment thesis for the next decade is not yet demonstrable with numbers

Terry Smith (Fundsmith) — 🟡 watch · 62/100 · medium confidence

Accenture passes most of the Fundsmith quality screen on fundamental metrics — ROIC of 26%, strong FCF conversion (~141% of net income), asset-light model with capex at <1% of revenue, and durable operating margins of ~14.7-17%. However, two of Smith's hardest red flags are flashing: (1) Accenture is now deploying ~$9B in acquisitions this fiscal year (vs. $5B guided), representing serial and escalating M&A that Smith explicitly distrusts, and (2) the near-term demand picture has fractured — 50% YTD price decline, lowered guidance, management saying 'more of the range is in play,' and genuine structural uncertainty about whether AI agents displace the FTE consulting model. The DCF implies $261/share intrinsic value vs. $128 current price (~103% upside), but the DCF relies on 4.2% FCF growth derived from a revenue CAGR that may be stale given guidance of 3-4% LCY for FY26 and decelerating bookings. The valuation is superficially compelling — P/FCF of 7.3x, P/E of 10.3x, price-to-sales of 1.1x — but Smith would ask whether the moat is intact. That question is genuinely open. The consulting model is people-intensive and the revenue per FTE economics could be disrupted by AI automation; management itself is pivoting toward cybersecurity software (Dragos ARR $208M at 48% growth) and mid-market platform plays precisely because the core model faces headwinds. The quality is real but impaired, and the M&A acceleration is a classic warning sign Smith flags. On the positives: ROCE has been consistently above 20%, FCF margins 13-16% across five years, current ratio >1.4, no visible debt-to-equity issue (though goodwill from acquisitions bears watching), and 195 of top 200 clients retained >10 years demonstrates genuine switching costs. Book-to-bill at 1.0 is not yet alarming but trending in the wrong direction. This is a borderline watch — quality business at a price that looks cheap, but facing a potentially structural moat challenge and an M&A strategy that dilutes capital discipline.

Key points

ROIC of 26.2% and ROE of 24.9% well above cost of capital — Fundsmith first test met across multiple years
FCF of $10.87B vs net income of $7.68B = 141% cash conversion ratio — profits are real and cash-backed
Capex only $600M on $69.7B revenue (<1%) — highly asset-light model consistent with Fundsmith preferences
Operating margin 14.7% (reported) / 17% Q3 FY26 and expanding (+20 bps YoY) — pricing power and cost discipline visible
195 of top 200 clients retained >10 years — strong switching costs and recurring revenue characteristics
Revenue CAGR of only 4.2% over 3 years — growth is modest, not compounding strongly
P/FCF of 7.3x is historically cheap for this quality level; DCF base case $261/share implies meaningful margin of safety
5%+ dividend yield with 10% raise and $9.5B+ total shareholder returns signal management confidence in FCF durability

Red flags

$9B M&A deployment this fiscal year (vs. $5B guided) — serial acquisitions across OT cybersecurity (Dragos, RunZero, NetRise), digital health, creative agencies; exactly the roll-up pattern Smith distrusts
Guidance language 'more of the range is in play' signals genuine earnings visibility problem — bottom-end EPS $13.78 implies downside risk
Structural AI disruption risk to core FTE consulting model is real and unresolved — management pivoting business model mid-flight, which increases execution risk
Stock down ~50% YTD (52-week high $307.77 vs current $128.98) — severe price dislocation could reflect market correctly pricing permanent impairment, not just temporary sentiment
Bookings flat (book-to-bill 1.0, -2% to -3% growth) — leading indicator of revenue is not growing; consulting bookings particularly weak
OT cybersecurity platform (Dragos ARR $208M) is tiny relative to $69.7B revenue base — non-FTE pivot is real in direction but not yet material in scale
Goodwill from aggressive M&A program will balloon; no current quantification in this fact base of existing goodwill/intangibles load
Federal business drag (~1.5% revenue impact) and Middle East headwind ($100M) may be more persistent than management guides

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Accenture presents a genuinely mixed picture through the Dalio macro/risk lens. On the positive side, the balance sheet is fortress-like: net cash position (~$9.6B cash, debt-to-equity essentially zero per filings), $10.9B FCF generation, minimal capex ($600M on $70B revenue), and a current ratio of 1.41. This is a self-funding business that does not need capital markets to survive a credit contraction — a key Dalio criterion. Geographic diversification is genuine: revenues span North America, Europe, and growth markets, with no single-country concentration. The business is asset-light and people-intensive, meaning it has neither heavy fixed-cost leverage nor floating-rate debt exposure that would crater in a higher-for-longer rate regime. However, several Dalio red flags are flashing. First, ACN is a discretionary enterprise services business — when corporations cut capex and consulting budgets in a stagflationary or recessionary regime, Accenture's consulting revenues compress. The Q3 FY2026 evidence is live: the company itself flagged 'more of the range is in play,' $100M Middle East headwind, managed services deals slipping, and consulting stuck in low single-digit growth. In a stagflation or deflationary bust box, this business is not resilient — clients defer transformation programs. Second, while ACN has pricing power in normal markets (strong brand, sticky relationships), its FTE-based model faces structural inflation pass-through risk from wage inflation (800K+ employees globally), and the question is whether it can raise bill rates fast enough to offset salary inflation. Historically it has, but this cycle may be different if AI agents commoditize consulting outputs. Third, the stock has already repriced 50% YTD — the valuation reset is real (10x PE, 7.3x FCF, 1.1x P/S) and the DCF intrinsic value ($261/share base, $215 bear) suggests substantial margin of safety. But from a Dalio regime perspective, this margin of safety only materializes if the earnings base holds. If AI structurally displaces FTE demand and consulting cycles down, earnings power is genuinely impaired, not temporarily depressed. Fourth, correlation: ACN is highly correlated to broad equity/tech in a risk-off environment — it adds limited diversification value to a typical equity book and its beta of 1.17 confirms it amplifies drawdowns. Fifth, the $9B M&A deployment (Dragos, cybersecurity platforms) adds execution risk and binds capital in illiquid private assets during a period of macro uncertainty. The debt-cycle position is concerning for customers: large enterprise clients (ACN's bread and butter) are themselves in a leverage consolidation phase, cutting discretionary IT spend, which directly pressures ACN's consulting pipeline. Overall: strong balance sheet and FCF durability earn real credit, but the discretionary demand profile, single-regime sensitivity (growth+low rates = good, stagflation = bad), and AI disruption overhang prevent a 'pass' verdict.

Key points

Net cash balance sheet (~$9.6B cash, near-zero net debt) is a genuine Dalio strength — self-funding through any credit cycle with no refinancing risk or maturity wall
FCF of $10.9B (15.6% margin) and operating cash flow of $11.5B demonstrate strong through-cycle cash generation with minimal capex intensity ($600M)
Geographic diversification across Americas, EMEA, and Asia-Pacific provides partial regime hedge against single-economy shocks
DCF intrinsic value ($215 bear, $261 base) at current $129 price implies 67-100% upside, but only if FCF base is not structurally impaired by AI displacement
Capital return discipline: $9.5B+ returned to shareholders (dividends + buybacks), 10% dividend raise, ROIC of 26.2% well above cost of equity

Red flags

Discretionary consulting demand is acutely pro-cyclical — management already flagging weakness from macro uncertainty, Middle East, and corporate budget tightening in FY2026, precisely what Dalio expects in a late-cycle slowdown
AI structural disruption risk: AI agents and LLMs may hollow out FTE-based consulting demand, representing a regime-independent impairment risk not captured in standard macro stress tests
Single-regime sensitivity: ACN underperforms in stagflation (margin compression from wage inflation + revenue contraction as clients cut budgets) and deflationary bust (consulting deferrals); works best in low-inflation growth
High equity market beta (1.17) means ACN adds correlation, not diversification, to a standard equity portfolio — the antithesis of Dalio's Holy Grail
$9B M&A deployment in a single year into private cybersecurity assets (Dragos, RunZero, NetRise) at elevated valuations introduces integration risk and capital lock-up during an uncertain macro window
Wage inflation pass-through risk: 800K+ employees globally creates a large, sticky cost base; if bill rate increases lag salary inflation in a high-inflation regime, margins compress structurally

Philip Fisher — 🟡 watch · 52/100 · medium confidence

Accenture presents a genuinely mixed picture through Fisher's lens. On the positive side, the company exhibits many hallmarks of a well-managed, durable franchise: deep client relationships (195 of top 200 for >10 years), candid management communication (explicitly flagging Middle East drag, managed services slippage, and 'more of the range is in play'), operating margin expansion (+20 bps YoY despite heavy reinvestment), strong FCF conversion ($10.9B FCF on $7.7B net income = 1.41x), and aggressive AI ecosystem positioning with 100 new advanced AI clients this quarter. The 124K promotions (30% YoY increase) and 900+ MD-level promotions signal management depth, not a one-man-band. However, Fisher's primary criterion is sustained above-average organic sales growth with a visible multi-year runway — and here ACN falls short. Revenue CAGR of just 4.19% over 3 years is not above-industry for a technology-services firm claiming AI leadership. Q3 FY2026 was only +3% LCY. The consulting segment — ACN's core organic engine — is explicitly guided to 'low single digits' for FY26, with management citing macro uncertainty, Middle East conflict, automotive sector weakness, and EMEA decision-cycle elongation as compounding headwinds. The $9B M&A spend this year (vs. $5B guided) is significant and raises Fisher's concern about 'bought rather than earned' growth — Dragos ARR of $208M at 48% growth is compelling but tiny relative to a $70B revenue base. The mid-market 'Accenture Edge' launch is unproven with no traction metrics. The structural AI disruption risk to FTE-based consulting is Fisher's deepest concern: if AI agents erode the need for large managed services headcounts, Accenture's volume growth engine may face secular compression rather than cyclical softness. Management's pivot toward non-FTE platform models is directionally correct but early-stage and unvalidated at scale. Fisher would want to scuttlebutt this more deeply — are enterprise clients genuinely deepening AI engagements, or are they using AI budget conversations to defer traditional consulting spend? The earnings call tone was candid (Fisher rewards this) but the guidance widening signals genuine uncertainty. At 10x PE and a DCF intrinsic of $261 (102% upside), valuation is not the Fisher concern — growth quality and organic runway are. This is a 'watch' until the consulting growth reaccelerates organically above low-single digits and the non-FTE platform mix shift shows measurable scale.

Key points

Revenue CAGR of 4.19% over 3 years is below Fisher's threshold for 'above-industry' growth for a technology-services firm claiming AI transformation leadership
Management demonstrated Fisher-style candor: explicitly flagging $100M Middle East headwind, managed services deal slippage to FY27, federal drag (~1.5%), and wider guidance range
Deep client franchise: 195/200 top clients >10 years, 104 clients with $100M+ quarterly bookings YTD (+13% YoY) — strong scuttlebutt evidence of relationship durability
FCF conversion of 1.41x net income ($10.9B vs $7.7B) and operating margin expansion (+20 bps) demonstrate cost discipline and margin protection even under reinvestment
Management depth visible: 124K promotions (30% YoY), 900+ to MD level; CEO Julie Sweet with clear strategic narrative on AI positioning
AI ecosystem partnerships (OpenAI, NVIDIA, Databricks, Anthropic, etc.) tracking >2x FY25 booking levels — genuine pipeline building
Dragos acquisition (48% ARR growth, OT security) and Accenture Edge mid-market launch represent real TAM expansion vectors, though unproven at scale

Red flags

Core organic growth stalling: Q3 FY2026 only +3% LCY; consulting guided to 'low single digits' for full year — Fisher demands above-industry organic volume growth
$9B M&A deployment this year (vs $5B guided) raises concern that inorganic acquisitions are masking organic growth weakness — 'bought not earned'
AI disruption is a genuine structural threat to FTE-based consulting economics: if AI agents reduce headcount needs, ACN's primary volume engine faces secular pressure, not cyclical softness
Accenture Edge (mid-market) and OT security platform are nascent with no traction data, unit economics, or go-to-market proof — Fisher wants demonstrated pipeline conversion, not concept
Guidance range widening ('more of the range is in play') signals low forward visibility — Fisher is wary of companies managing to a wide band rather than with confidence
Stock down ~50% YTD partly reflects market pricing structural impairment risk, not just cyclical; options market showing unusual put/call hedging activity
Management's R&D analog (consulting IP, AI tooling) not explicitly quantified in the fact base — unable to assess whether Accenture is investing at above-peer rates in AI-native capabilities

Seth Klarman — 🟡 watch · 52/100 · medium confidence

Accenture presents a genuinely interesting value situation after a ~50% YTD collapse, but falls short of a clear Klarman-style pass for several reasons. The stock now trades at ~10x earnings, ~7x FCF, and 1.1x sales — metrics that would attract attention from any value investor. The DCF intrinsic value of $261/share implies ~100% upside, and even the bear case at $215 represents significant discount to current price of $129. However, as Klarman emphasizes, the margin of safety must be stress-tested against the downside first, and that exercise raises concerns. The critical question is whether this is a temporary dislocation (orphaned stock, panic selling, forced selling by growth/quality funds exiting after multiple compression) or a genuine structural impairment of the business model. The AI disruption narrative — that LLMs and AI agents hollow out Accenture's labor-arbitrage consulting model — is not dismissible as pure noise. Management's own Q3 FY2026 guidance language ('more of the range is in play') and the 18.9% single-day crash after Q3 earnings signal meaningful fundamental deterioration, not just technical selling. The balance sheet is genuinely solid: ~$9.6B in cash, no meaningful debt (debt-to-equity not reported but current ratio 1.41, equity of $30.9B vs $64.7B assets), and $10.9B in annual FCF. This creates real downside protection — the company cannot be zeroed out, and the asset base is liquid enough to sustain capital returns even in a slowdown. The 15.6% FCF margin and ROIC of 26% are hallmarks of a quality franchise. However, the conservatism required by margin-of-safety principles demands asking: what if the AI disruption thesis has merit and consulting revenues decline 15-20%? FCF could fall to $7-8B, which at 12-15x still supports a $130-180/share range — barely clearing or matching current price. The goodwill and intangible-heavy balance sheet (total assets $64.7B vs stockholders equity $30.9B, with significant goodwill from acquisitions) means liquidation value is substantially below book. The $9B M&A deployment into OT cybersecurity (Dragos at $208M ARR, 48% growth but tiny relative to $70B revenue base) is strategic optionality, not near-term value crystallization. The revenue CAGR of only 4.2% over 3 years and consulting-in-low-single-digits guidance for FY2026 argue against DCF assumptions that may be too optimistic even at 4.2% growth. The technical dislocation element is real: growth/quality fund exodus, index reweighting pressure, forced selling by momentum funds — these are structural, temporary forces Klarman exploits. The ~5% dividend yield provides a cash return while waiting. Missing from the thesis: no hard catalyst to close the gap, no spinoff, no asset sale, no activist involvement disclosed. Management's $9B M&A spend actually complicates the thesis by increasing complexity and integration risk rather than simplifying for value realization. The position is 'watch' rather than 'pass' — the price is approaching the zone where Klarman would build a small initial position, but the AI structural disruption risk is not yet adequately stress-tested, and the lack of a specific catalyst means patience could be tested for years ('dead money' scenario per bears). Additional due diligence on the pace of AI substitution for consulting FTEs and normalized FCF under a bear scenario is required before a full position is warranted.

Key points

Price/FCF of 7.3x and P/E of ~10x represent meaningful discount to historical multiples and to the two-stage DCF intrinsic value of $261/share (bear case $215); significant spread to a conservative going-concern value
Balance sheet is genuinely solid: $9.6B cash, minimal net debt (negative net debt per DCF assumptions), current ratio 1.41, $10.9B annual FCF — real downside protection and capital return capacity (~$9.5B returned to shareholders guided for FY26)
~50% YTD price collapse shows hallmarks of structural/technical forced selling: growth fund exodus, multiple compression, momentum reversal — the type of orphaned-stock dislocation Klarman exploits
ROIC of 26%, 16% FCF margin, 195 of top 200 clients retained >10 years, 104 clients with $100M+ bookings — franchise durability is high, arguing against outright bear case of permanent impairment
Revenue CAGR only 4.2% over 3 years; consulting guided at low-single-digit growth for FY2026; book-to-bill of 1.0 not inspiring; FCF assumption in DCF at 4.2% growth may still be optimistic if AI disruption accelerates

Red flags

No hard catalyst to close valuation gap — no spinoff, sale, restructuring, or activist involvement; the stock could remain 'dead money' for years without a specific event to surface value
AI structural disruption risk is material and non-trivial: if AI agents reduce consulting FTE demand by 15-20%, normalized FCF could fall to $7-9B, compressing the margin of safety substantially at current prices
$9B M&A deployment (Dragos, RunZero, NetRise, Alpha Health) increases complexity and integration risk; OT security acquisitions are subscale ($208M ARR) relative to $70B revenue base and may not offset consulting headwinds
Balance sheet asset quality is impaired in liquidation: significant goodwill/intangibles in $64.7B asset base means true liquidation value (net-net) is far below equity book value, limiting hard asset downside floor
Management guidance language 'more of the range is in play,' $100M Middle East revenue drag, managed services deals slipping to FY27 — forward earnings visibility is genuinely low, making normalized FCF estimation unreliable
DCF residual value is 70.6% of total enterprise value, concentrated in terminal value assumptions; small changes in terminal growth or WACC drastically alter intrinsic value, reducing confidence in the $261 base case

Peter Lynch — 🟡 watch · 52/100 · high confidence

Accenture is a classic Lynch 'stalwart' — a giant, well-understood business ($70B revenue, 800K employees) with durable client relationships and consistent earnings. The story is simple: Accenture sells consulting and managed services to large enterprises, earns predictable fees, and grows modestly. By Lynch stalwart criteria, I'd typically buy a stalwart at a 30-50% gain and sell when it gets expensive. ACN is now doing the opposite — it has crashed 50% YTD to 10x PE, which is eye-catching. But the Lynch PEG framework cuts both ways: the PEG as reported is 2.45 (factbase), which assumes a growth rate implied by revenue CAGR of ~4.2%. Even adjusting for the ~5% dividend yield (yield-adjusted PEG), EPS growth is only in the 7-9% range (FY2026 guidance: 7-8% EPS growth). A stalwart deserves a PEG of roughly 1.0-1.5. At 10x PE and 8% EPS growth, the raw PEG is ~1.25, which is actually acceptable for a stalwart — Lynch's stalwart sweet spot. Adding the ~5% dividend yield, yield-adjusted PEG drops to roughly 0.77, which is genuinely attractive. So why only a 52? Several Lynch red flags are flashing: (1) Diworsification risk is real — $9B in acquisitions this year, pivoting into OT cybersecurity platforms (Dragos, RunZero, NetRise) that are far outside Accenture's consulting DNA. Lynch hated companies leaving their circle of competence to chase hot sectors. (2) Earnings growth is decelerating — revenue CAGR is only 4.2% over 3 years, Q3 LCY growth was just 3%, and management said 'more of the range is in play' on guidance. For a stalwart, 3-4% top-line growth is borderline slow-grower territory. (3) The story is getting complicated: federal headwinds, Middle East drag, managed services pushouts, now a mid-market unit (Accenture Edge), cybersecurity platforms, and AI-as-a-tailwind narratives. Lynch wants a story he can explain in two sentences; ACN is drifting toward a complex restructuring narrative. (4) The primary growth thesis now relies heavily on AI transformation spending materializing — which is a 'next big thing' bet, not a Lynch-style visible and repeatable roll-out formula. On the positive side: balance sheet is strong (net cash $9.6B, no meaningful debt-to-equity), FCF is excellent ($10.9B, 15.6% margin), buybacks and a 10% dividend raise show capital discipline, and 195 of top 200 clients have 10+ year relationships (Lynch loves loyal customers). The stock is not neglected (high institutional coverage) but at 50% off its high, the crowding that Lynch feared has been flushed. The absolute PE of 10x is not stretched for a stalwart if earnings hold. This is a hold-and-watch for a Lynch stalwart investor: attractive if earnings stabilize, but too many moving parts and diworsification signals to go full pass.

Key points

Stalwart classification: $70B revenue, 11% net margin, 16% FCF margin, durable client base — textbook Lynch stalwart, not a fast grower
Yield-adjusted PEG ~0.77 (10x PE / 8% EPS growth + 5% yield) is actually attractive for a stalwart; raw PEG ~1.25 is in acceptable range
Balance sheet: net cash $9.6B, no reported debt-to-equity, current ratio 1.41 — Lynch-quality financial fortress
FCF $10.9B (15.6% margin), ROIC 26% — the underlying business generates exceptional cash on capital
50% YTD decline has flushed excessive valuation premium; stock no longer the 'hot' high-multiple name Lynch avoids
195/200 top clients with 10+ year tenure and 104 clients with $100M+ quarterly bookings — repeatable, sticky revenue base
Aggressive buybacks + 10% dividend raise signal management confidence in FCF durability

Red flags

Diworsification: $9B in acquisitions pivoting into OT cybersecurity (Dragos, RunZero, NetRise) — Lynch's classic red flag of abandoning core competency
EPS growth guided at 7-8% for FY26 — stalwart territory, but management language ('more of the range is in play') raises downside risk to even that modest rate
Revenue CAGR only 4.2% over 3 years; Q3 LCY growth 3% — approaching slow-grower territory, which erodes even a 10x PE story
Story complexity rising: AI transformation pivot, mid-market launch (Accenture Edge unproven), OT security platform stitching, federal headwinds, Middle East drag — Lynch wants simple, explainable stories
AI disruption threat to core FTE consulting model is real and structural — not a cyclical headwind but a potential moat erosion
Managed services deal pushouts and federal drag are near-term headwinds with unclear resolution timelines
$9B M&A at elevated cybersecurity valuations risks capital destruction; Dragos $208M ARR is tiny relative to $70B revenue base

AI & Disruption Referee (Christensen-style) — 🟡 watch · 48/100 · medium confidence

Accenture is the canonical test case for AI disruption of professional services: its core product is human expertise (consulting, systems integration, managed services, BPO) packaged into labor-hour contracts. This is precisely the category where LLMs are most capable. The disruption mechanism is specific: AI agents and code-generation tools lower the number of billable FTEs needed to deliver the same output, compressing either revenue per engagement or headcount demand. The 50% YTD stock decline reflects the market pricing this structurally, not just cyclically. However, the picture is genuinely mixed — Accenture is not a passive victim. Three factors complicate a clean 'avoid': (1) It has been aggressively acquiring AI capability (Dragos ARR $208M at 48% growth, Alpha Health, Whaler; OT cybersecurity platform) and embedding non-FTE recurring revenue. (2) It operates at the top of enterprise complexity — large-scale transformation programs requiring multi-system integration, change management, and regulatory navigation — which is not easily replicated by an LLM plus first-party data; the scarcest input is client-org access and trust, not raw analysis. (3) Management has named the threat explicitly and is structurally repositioning (Accenture Edge for mid-market, non-FTE commercial models, ecosystem bookings with OpenAI/NVIDIA/Databricks growing 2x). The core concern is velocity: can the non-FTE platform pivot scale fast enough to offset FTE-model margin compression before clients internalize AI capabilities? The Dragos/RunZero/NetRise cluster is real but ~$208M ARR against a $70B+ revenue base is de minimis. The mid-market Edge launch is unproven. Managed services is partly sticky but also vulnerable if hyperscalers (Microsoft/Azure AI, AWS, Google Cloud) bundle consulting-adjacent automation. The falsifiable call: if 3-year consulting revenue CAGR turns negative AND take-rates compress below 13% FCF margin, that confirms structural displacement; if OT security ARR reaches $1B+ and non-FTE revenue mix exceeds 15% of total by FY2028, the pivot is working. Right now the evidence is insufficient to call either direction confidently — hence 'watch' rather than 'avoid'.'

Key points

Core FTE-consulting model is directly in the AI displacement zone: the unit of value (analyst/developer/BA hours) is what LLMs are most rapidly automating; this is not a second-order risk
Management explicitly acknowledges the threat and is repositioning: OT cybersecurity acquisitions (Dragos 48% ARR growth), non-FTE commercial models, mid-market Edge launch targeting $240B TAM show genuine strategic response, not denial
Enterprise transformation complexity provides partial moat: multi-system integration at Fortune 500 scale, regulatory navigation, and organizational change management are not easily automated by off-the-shelf models; client-org trust is a real barrier
Hyperscaler encirclement is the deepest risk: Microsoft (Avanade JV aside), AWS, and Google are all building consulting-adjacent AI automation that competes directly with Accenture's managed services delivery layer
Non-FTE pivot is real but sub-scale: ~$208M Dragos ARR is <0.3% of $70B revenue base; the platform shift needs 3-5 years to be material, and the market is pricing in doubt that it arrives in time
Q3 FY2026 bookings flat (book-to-bill 1.0) with consulting under pressure and managed services slipping to FY27 are early leading indicators of demand compression consistent with client AI insourcing
FCF margin held at 15.6% and operating margin expanding 20bps — so current economics are still strong; the Christensen trap is flagged explicitly: cheap multiple on strong current cash flows may be the market pricing forward demand destruction, not a value opportunity

Red flags

Revenue rests on FTE labor and expertise: consulting and managed services together are the exact category LLMs automate; unit economics compress if FTE productivity rises without offsetting volume growth or price increases
Microsoft/OpenAI hyperscaler encirclement: Accenture's Avanade JV with Microsoft is an asset, but Microsoft also has direct financial incentive to push Copilot as a substitute for Accenture consulting hours; the JV partner is also the key competitive threat
Consulting growth already in low single digits: management guided consulting to remain in low-single-digit growth FY26, a significant deceleration that precedes visible FTE demand destruction if AI acceleration continues
Guidance range widening ('more of the range is in play') signals low conviction in near-term demand; this language, combined with $100M Middle East headwind and managed services slippage, suggests structural and cyclical headwinds compounding
Accenture Edge unproven: newly launched mid-market product with no disclosed unit economics, GTM traction, or conversion metrics; framed as TAM expansion but could cannibalize existing consulting margin in mid-market segment
Options market unusual put/call activity post-earnings (Barchart) signals institutional hedging against further guidance misses, consistent with ongoing demand uncertainty
Stock down 50% YTD while earnings only modestly declining: the market is pricing forward disruption, not just a cyclical dip — this is the classic Christensen signal the value lenses risk misreading as 'cheap'

Stanley Druckenmiller — 🔴 avoid · 28/100 · high confidence

ACN fails the Druckenmiller framework on nearly every critical dimension. The tape is catastrophic — stock down ~50% YTD, at 52-week lows, with no price confirmation of any thesis. The second derivative on fundamentals is negative: consulting growth guided to low single digits, managed services deals slipping to FY27, Middle East headwinds of ~$100M with no clear resolution, and management explicitly widening the guidance range ('more of the range is in play'). Bookings of $19.3B showed a 2-3% decline LCY — not an inflection, a deceleration. This is the opposite of what I need: I need earnings accelerating, revisions going UP, and price confirming. Here I have earnings risk to the downside, Truist cutting PT, unusual options activity implying hedging demand, and a tape in free fall. The AI disruption narrative (agents hollowing out FTE consulting economics) is a genuine structural threat to the earnings model, not a temporary headwind — and it is unresolvable with a single catalyst. The forward earnings direction is unclear at best and deteriorating at worst. Yes, the DCF suggests intrinsic value of ~$261 vs $128 price, and FCF is real ($10.9B, 15.6% margin), but a cheap backward-looking valuation with a rolling-over fundamental trend is exactly the 'backward-looking cheap trap' I am wired to avoid. The liquidity/monetary regime context is ambiguous — no clear Fed easing wave acting as tailwind. There is no identifiable catalyst or timing edge: the new Accenture Edge mid-market product just launched with zero metrics, the OT cybersecurity acquisitions are small ($208M ARR) relative to a $70B revenue base, and federal headwinds have no clear resolution path. I cannot size a concentrated position in a name where the tape disagrees, the second derivative is negative, the earnings range is widening downward, and there is no defined asymmetric catalyst. This is a value investor's restructuring story, not a momentum macro bet.

Key points

Stock down ~50% YTD, trading at 52-week lows — tape violently disagrees with any bullish thesis; price confirmation is a prerequisite for me to size up
Second derivative negative: Q3 bookings declined 2-3% LCY, consulting guided to low single digits, managed services slipping to FY27, no acceleration in sight
Management's own language ('more of the range is in play') signals low visibility and potential downside to $13.78 EPS floor — estimate revision risk is to the downside
FCF is real and DCF implies massive upside ($261 intrinsic), but this is precisely the 'backward-looking cheap trap' — trailing multiples look attractive while forward direction deteriorates
No asymmetric catalyst: Accenture Edge is unproven, OT cybersecurity acquisitions ($208M ARR) are tiny vs. $70B base, and AI disruption is a structural headwind not a timing event I can trade around
Sell-side cutting PTs, options market pricing elevated volatility, retail sentiment fragile — no positive inflection in any leading indicator I track

Red flags

Tape in free fall: -50% YTD, no base formation, no relative strength — my #1 disqualifier is fighting the tape
Decelerating fundamentals: bookings down, consulting soft, managed services delayed, guidance range widened — second derivative turning lower
AI structural disruption to FTE consulting economics is an unresolvable multi-year headwind, not a cyclical bump I can look through
No defined invalidation point that gives me trading discipline — the thesis is open-ended and murky
Truist PT cut post-earnings + unusual options put/call activity = institutional distribution, not accumulation
M&A deployment of $9B this year (vs. $5B guided) into cybersecurity platforms while core consulting weakens adds execution risk and capital allocation uncertainty at the worst time

Walter Schloss — 🔴 avoid · 22/100 · high confidence

Accenture is a large-cap professional services and technology company whose balance sheet is dominated by intangibles, goodwill, and human capital — not the hard tangible assets that form the bedrock of a Schloss-style valuation. Price-to-book stands at 2.56x, which is already above my comfort zone, but the situation is worse on a tangible basis: with $64.7B total assets and $30.9B stockholders' equity, a significant portion of that book is likely goodwill and acquired intangibles from decades of acquisitions (the filings confirm ongoing M&A, now $9B deployed in FY26 alone). Tangible book value per share is likely a fraction of the stated $30.9B book, making price-to-tangible-book substantially higher than 2.56x — potentially 5-10x or more. The 52-week context is striking: the current price of $128.98 IS the 52-week low (the data shows high_52w = $128.98 = last_close, which appears to reflect a post-crash price after a ~50% YTD decline from ~$307 high), meaning the stock has crashed dramatically. That part interests me — I like beaten-down names. But the asset base does not support a Schloss floor. Accenture's 'assets' are its 798K+ employees, client relationships, brand, and methodologies — none of which appear on the balance sheet at recoverable value in a liquidation. Working capital shows current assets of $28.1B vs. current liabilities of $19.9B, giving net current assets of ~$8.2B, or roughly $12.87/share — far below the $128.98 price. There is no net-net or near-net-net opportunity here. Debt-to-equity is listed as null (suggesting minimal long-term financial debt, which is a positive), and the balance sheet is not dangerously leveraged, but leverage is not the issue — the issue is that the assets simply aren't there in tangible form to provide a margin of safety. The business is also complex: a global professional services firm with government contracts, geopolitical exposures (Middle East headwind), aggressive M&A (Dragos, RunZero, NetRise, Alpha Health), and a rapidly evolving AI competitive dynamic. This is not a simple business I can appraise from the filings. The investment thesis for bulls rests almost entirely on earnings power, AI optionality, and DCF — exactly the growth narrative and forecast dependency I avoid. The dividend yield (~5% at current price) is attractive and cash generation is strong ($10.9B FCF), but a dividend alone does not substitute for asset-based margin of safety. The price decline is real and interesting, but Accenture at $129 is still a 'quality compounder' story, not a statistical bargain in hard assets.

Key points

Price-to-book of 2.56x overstates asset protection; tangible book is materially lower given substantial goodwill/intangibles from ongoing M&A
Net current assets (~$8.2B, ~$12.87/share) provide no floor near the $128.98 price — far from a net-net
No meaningful long-term debt (D/E null) is a genuine positive — balance sheet not leveraged dangerously
Stock has crashed ~50% YTD and sits near multi-year lows — the price action pattern I like — but asset base doesn't support a floor
Strong FCF ($10.9B) and 5%+ dividend yield are attractive, but FCF power is an earnings forecast, not a hard asset
Business is complex (798K employees, global geopolitical exposures, active M&A, AI transition) — too complex for my style

Red flags

Price-to-tangible-book likely 5-10x or higher; book value dominated by goodwill/intangibles from acquisitions
Investment thesis is entirely earnings/growth/AI optionality dependent — no hard asset floor
$9B M&A in FY26 further adds intangibles to balance sheet, diluting tangible asset base
Middle East headwind, managed services slippage, federal drag all signal near-term earnings uncertainty — no asset cushion to absorb shocks
Complex, opaque global services business; difficult to appraise from filings alone
Insider ownership data not available in fact base — cannot verify alignment

Fact base appendix

Price

last_close: 128.98
as_of: 2026-06-27
high_52w: 128.98
low_52w: 128.98
pct_below_52w_high: 0.0

Fundamentals

last_price: 128.98
market_cap: 78928296855
fifty_two_week_high: 307.77
fifty_two_week_low: 118.15
beta: 1.166447
currency: USD
exchange: NEW YORK STOCK EXCHANGE, INC.
sector: Technology
industry: Technology
price_source: finnhub
bars: 1
entity: Accenture plc
fiscal_year: 2025
revenue: 69672977000
revenue_period: 2025-08-31
net_income: 7678433000
net_income_period: 2025-08-31
operating_income: 10225664000
operating_income_period: 2025-08-31
operating_cash_flow: 11474399000
operating_cash_flow_period: 2025-08-31
capex: 600039000
capex_period: 2025-08-31
total_assets: 64698463000
total_assets_period: 2025-11-30
current_assets: 28066694000
current_assets_period: 2025-11-30
current_liabilities: 19896521000
current_liabilities_period: 2025-11-30
stockholders_equity: 30867503000
stockholders_equity_period: 2025-11-30
cash_and_equivalents: 9649405000
cash_and_equivalents_period: 2025-11-30
shares_outstanding: 637016143
operating_margin: 0.1468
net_margin: 0.1102
roe: 0.2488
debt_to_equity: None
current_ratio: 1.4106
roic: 0.2617
free_cash_flow: 10874360000
fcf_margin: 0.1561
pe_ratio: 10.28
price_to_fcf: 7.26
price_to_sales: 1.13
revenue_cagr: 0.0419
revenue_cagr_years: 3
fundamentals_source: edgar_companyfacts
price_to_book: 2.56
earnings_yield: 0.1476
peg: 2.45

Filings reviewed

8-K (2026-06-23) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000035/acn-20260623.htm
10-Q (2026-06-18) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000032/acn-20260531.htm
8-K (2026-06-18) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000031/acn-20260618.htm
10-Q (2026-03-19) https://www.sec.gov/Archives/edgar/data/1467373/000146737326000014/acn-20260228.htm
10-K (2025-10-10) https://www.sec.gov/Archives/edgar/data/1467373/000146737325000217/acn-20250831.htm
10-K (2024-10-10) https://www.sec.gov/Archives/edgar/data/1467373/000146737324000278/acn-20240831.htm

Other sources

[news] Accenture PLC Cl A stock outperforms competitors on strong trading day - MarketWatch
[news] Accenture PLC Cl A stock underperforms Thursday when compared to competitors - MarketWatch
[news] Here is What to Know Beyond Why Accenture PLC (ACN) is a Trending Stock - Yahoo Finance
[news] Wall Street Expects Accenture plc (ACN) to Bounce Back Despite a 50% YTD Decline - Yahoo Finance
[news] Why Accenture Stock Opened 18.9% Lower Today - The Motley Fool
[news] Why Accenture Stock Opened 18.9% Lower Today - Yahoo Finance
[news] Is Trending Stock Accenture PLC (ACN) a Buy Now? - Yahoo Finance
[news] Accenture Plc Class A Actuals & Estimates (TURQUOISE:ACNN) - TradingView
[news] Accenture Shares Plunged 50% This Year. Here's What Investors Need to Know. - The Motley Fool
[news] Truist Cuts PT on Accenture (ACN) Following Q3 Report - Insider Monkey
[news] Accenture Plc Class A Actuals & Estimates (FWB:CSA) - TradingView
[news] Accenture Plc Class A Actuals & Estimates (NYSE:ACN) - TradingView
[news] Why Accenture Stock Looks Undervalued After Eight Quarters of Expanding Operating Margins - TIKR.com
[news] Accenture PLC Has Huge Unusual Put and Call Options Activity After Lower Guidance - Barchart.com
[news] Accenture PLC Cl A stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
[discussion] $ACN I mean yeah it’s 10 PE now ACN is basically priced to lose 1/3-1/2 of its business at this poin
[discussion] $ACN AI agents are structurally disrupting traditional enterprise software subscription economics, w
[discussion] $ACN Tech needs big 'staff' to die to prove concept. It will be shorted to hell, even if th
[discussion] [Bullish] The market is now pricing in -9.8% free cash flow growth annually for accenture over the n
[discussion] [Bearish] $ACN It's called dead money, best case you just grind away for years around this level
[discussion] $ACN I thought there would have been more of a bounce by now with the buyback news… but just the ste
[discussion] Still holding $SERV $MU $ACN $U. The market is pricing in long-term conviction holding, but I think
[discussion] [Bullish] $ACN
[discussion] [Bullish] $ACN being bearish with a 5% dividend is way out there!
[discussion] $ACN CRYPTO WINTER IN SUMMER
[discussion] $ACN The managing directors have been awfully quiet on LinkedIn regarding all this. They’ve lost mil
[discussion] $ACN strong after hours
[discussion] $ACN initiated last Thursday and added across two times this week. love this one as a core long-term
[discussion] $ACN Current Stock Price: $125.83 Contracts to trade: $125.0 ACN Jun 26 2026 Call Entry: $1.45 Exit:
[discussion] [Bullish] $NOW $IGV $MSFT $ADBE $ACN Massive destruction of wealth across the software, technology
[earnings_call] Accenture Q3 2026 Earnings Call |Mid-Market Edge Launch Outlined as AI Tailwinds Drive 9% EPS Growth

Generated 2026-07-17T19:11:32 · est. cost $1.52

What each investor thinks

Valuation Referee (Damodaran-style) Referee

pass · 82

Joel Greenblatt Value

pass · 78

Charlie Munger Quality

pass · 78

Warren Buffett Quality

pass · 76

Bruce Greenwald Value

pass · 76

Howard Marks Risk

pass · 74

Michael Mauboussin Quality

pass · 74

Moat Assessment (Concrete, Not Adjective):

Switching Costs (Wide): 195 of top 200 clients have relationships >10 years. Multi-year managed services and transformation programs create deep procedural, relational, and financial exit costs. Clients running core operations on Accenture-managed infrastructure face enormous switching friction. This is the primary moat source — high, durable, evidenced by client concentration and longevity.
Scale Economies (Narrow-to-Wide): $70B revenue base enables unique investment in proprietary AI tools, training infrastructure (124K promotions, 900+ MDs), and ecosystem relationships (OpenAI, NVIDIA, Anthropic, Databricks, Snowflake at 2x bookings YoY). No PE-backed or regional competitor can match this investment capacity. However, per-FTE economics are largely commodity unless Accenture can shift to non-FTE models.
Network Effects (None-to-Narrow): Limited direct network effects in traditional consulting. The ecosystem model (top-10 AI partner bookings, Avanade JV) is an indirect platform effect in early development. Not a primary moat driver today.
Intangibles (Narrow): Brand is real but not a pricing-power moat in the classical sense — clients negotiate hard. The moat from intangibles comes from proprietary IP in delivery methodology and the talent/culture flywheel.
Moat Trajectory: Eroding at the margin (consulting FTE model) but potentially re-widening via non-FTE platform acquisitions (Dragos at $208M ARR/48% growth, Alpha Health, Accenture Edge). The strategic bet is whether the platform shift succeeds faster than consulting margin compresses. This is the key uncertainty.

What Would Change My Mind (Disconfirming Tests):

ROIC falling below 20% for two consecutive years (spread narrowing materially)
Book-to-bill falling below 0.95 for two quarters (demand destruction confirmed)
Managed services margins compressing >200 bps without recovery (FTE cost structure not offsetting)
Accenture Edge showing minimal adoption in 12 months (mid-market strategy fails)
OT cybersecurity ARR growth decelerating materially post-acquisition (integration failure)

Benjamin Graham Value

pass · 72

Forensic Short-Seller (Chanos/Einhorn-style) Referee

pass · 72

Chuck Akre Quality

watch · 62

Terry Smith (Fundsmith) Quality

watch · 62

Ray Dalio Risk

watch · 52

Philip Fisher Growth

watch · 52

Seth Klarman Value

watch · 52

Peter Lynch Growth

watch · 52

AI & Disruption Referee (Christensen-style) Referee

watch · 48

Stanley Druckenmiller Risk

avoid · 28

Walter Schloss Value

avoid · 22

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →